{{Featured article}}
{{not|乙醯胺酚}}
{{NoteTA|G1=Chemistry|G2=Medicine|G3=Math}}
{{medical}}
{{Infobox drug
| drug_name = 阿司匹林<br>Aspirin
| type = 
| IUPAC_name = 2-Acetoxybenzoic acid
| image = Aspirin-skeletal.svg
| width = 100px
| alt = 
| caption = 
| image2 = Aspirin-B-3D-balls.png
| width2 = 125px

<!--Clinical data-->
| pronounce = acetylsalicylic acid {{IPAc-en|ə|ˌ|s|iː|t|əl|ˌ|s|æ|l|ᵻ|ˈ|s|ɪ|l|ᵻ|k}} 
| tradename = [[拜耳|拜耳阿斯匹林]]和其他
| Drugs.com = {{drugs.com|monograph|aspirin}}
| MedlinePlus = a682878
| licence_EU = 
| licence_US = Aspirin
| pregnancy_AU = C
| pregnancy_US = C
| pregnancy_US_comment = D （第三孕期）
| pregnancy_category = 
| legal_AU = S2
| legal_AU_comment = 針劑型除外（屬於schedule 4類藥物），若用於動物則為 schedule 5/6 。高劑量阿斯匹靈也不一樣。
| legal_UK = GSL
| legal_US = OTC
| legal_CN = OTC-B
| legal_status = 
| routes_of_administration = 通常为[[口服|口服]]，也可以直肠给药。來欣阿斯匹林（lysine acetylsalicylate）則可透過[[靜脈注射|靜脈注射]]或[[肌肉注射|肌肉注射]]

<!--Pharmacokinetic data-->
| bioavailability = 80–100%<ref name=MSR>{{cite web|title=Zorprin, Bayer Buffered Aspirin (aspirin) dosing, indications, interactions, adverse effects, and more|work=Medscape Reference|publisher=WebMD|accessdate=2014-04-03|url=http://reference.medscape.com/drug/zorprin-bayer-buffered-aspirin-343279#showall|deadurl=no|archiveurl=https://web.archive.org/web/20140407080151/http://reference.medscape.com/drug/zorprin-bayer-buffered-aspirin-343279#showall|archivedate=2014-04-07}}</ref>
| protein_bound = 80–90%<ref name = MD>{{cite web|title=Aspirin|work=Martindale: The Complete Drug Reference|publisher=Pharmaceutical Press|date=2014-01-14|accessdate=2014-04-03|url=http://www.medicinescomplete.com/mc/martindale/current/2601-s.htm|editor=Brayfield, A|archive-date=2019-07-13|archive-url=https://web.archive.org/web/20190713075909/https://about.medicinescomplete.com/|dead-url=no}}</ref>
| metabolism = [[肝脏|肝脏]]（[[CYP2C19|CYP2C19]]，也可能是{{le|CYP3A|CYP3A}}），也有部分在肠壁水解为水杨酸盐<ref name = MD/>
| elimination_half-life = 视药量而定；低剂量时为2-3小时（100 mg 以下時），高剂量时为15-30小时<ref name = MD/>
| excretion = 尿液（80–100%）、汗、唾液、粪便<ref name = MSR/>

<!--Identifiers-->
| CAS_number = 50-78-2
| CAS_number_Ref = {{cascite|correct|??}}
| ATC_prefix = A01
| ATC_suffix = AD05
| ATC_supplemental = {{ATC|B01|AC06}}, {{ATC|N02|BA01}}
| PubChem = 2244
| IUPHAR_ligand = 4139
| DrugBank = DB00945
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| ChemSpiderID = 2157
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| UNII = R16CO5Y76E
| UNII_Ref = {{fdacite|correct|FDA}}
| KEGG = D00109
| KEGG_Ref = {{keggcite|correct|kegg}}
| ChEBI = 15365
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 25
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| PDB_ligand = AIN

<!--Chemical data-->
| synonyms = 邻-乙酰水杨酸<br/>2-乙酰氧基苯甲酸<br/>2-acetoxybenzoic acid<br />acetylsalicylate<br />acetylsalicylic acid<br />O-acetylsalicylic acid
<!--| BAN = Aspirin
| USAN = Aspirin-->
| C = 9
| H = 8
| O = 4
| molecular_weight = 180.158 g/mol<ref name=b92/>
| smiles = O=C(C)Oc1ccccc1C(=O)O
| StdInChI = 1S/C9H8O4/c1-6(10)13-8-5-3-2-4-7(8)9(11)12/h2-5H,1H3,(H,11,12)
| StdInChIKey = BSYNRYMUTXBXSQ-UHFFFAOYSA-N
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| density = 1.40
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| melting_point = 136
| melting_notes=<ref name=b92>{{RubberBible92nd|page=3.8}}</ref>
| boiling_point = 140
| boiling_notes = （分解）
| solubility = 3
| verifiedrevid = 464364671
| INN = acetylsalicylic acid
| Watchedfields = changed
}}
<!-- Definition and medical uses -->
'''阿司匹林'''<ref group="注">或译作'''-{zh-hans:阿司匹灵;zh-hant:阿士匹靈}-'''、'''-{zh-hans:阿斯匹灵;zh-tw:阿司匹林;zh-hk:阿斯匹靈}-'''、'''-{zh-hans:阿士匹灵;zh-hk:阿司匹林;zh-tw:阿士匹靈;}-'''</ref>（{{lang-en|Aspirin}}），也称'''乙醯柳酸'''、'''-{zh-hans:乙酰水杨酸;zh-tw:乙醯水楊酸}-'''（{{lang-en|acetylsalicylic acid}}，簡稱：ASA），是一種[[水杨酸|水杨酸]]类[[药物|药物]]，通常用作止痛剂、{{link-en|解热药|antipyretic}}和[[消炎药|消炎药]]<ref name=AHSF2016>{{cite web|title=Aspirin|url=https://www.drugs.com/monograph/aspirin.html|website=Drugs.com|publisher=American Society of Health-System Pharmacists|accessdate=2016-08-30|date=2016-06-06|deadurl=no|archiveurl=https://web.archive.org/web/20170425142242/https://www.drugs.com/monograph/aspirin.html|archivedate=2017-04-25}}</ref>，亦能用於治療某些特定的[[發炎性疾病|發炎性疾病]]，例如[[川崎氏病|川崎氏病]]、[[心包炎|心包炎]]，以及[[風溼熱|風溼熱]]等等<ref name=AHSF2016/>。[[心肌梗塞|心肌梗塞]]後馬上給藥能降低死亡的風險<ref name=AHSF2016/>。本品也能防止[[血小板|血小板]]在[[血管|血管]]破损处凝集，有[[抗凝劑|抗凝]]作用。高心血管風險患者长期低剂量服用可预防[[心脏病|心脏病]]、[[中风|中风]]与[[血栓|血栓]]<ref name=AHSF2016/>。该药还可有效预防特定幾种[[癌症|癌症]]，特别是[[直肠癌|直肠癌]]<ref>{{cite journal|last1=Patrignani|first1=P|last2=Patrono|first2=C|title=Aspirin and Cancer.|journal=Journal of the American College of Cardiology|date=2016-08-30|volume=68|issue=9|pages=967–76|pmid=27561771|doi=10.1016/j.jacc.2016.05.083}}</ref>。對於[[止痛|止痛]]及[[發燒|發燒]]而言，[[口服|口服]]後藥效一般會於30分鐘內發揮<ref name=AHSF2016/>。阿司匹林是一种[[非甾体抗炎药|非甾体抗炎药]]（NSAID），在[[抗炎性|抗發炎]]的角色上與其他NSAID類似，但阿斯匹靈還具有抗[[血小板|血小板]]凝集（antiplatelet）的效果<ref name=AHSF2016/>。

<!-- Adverse effects，此段更新至2018/1/23-->
阿司匹林的其中一個常見的[[不良反应_(医学)|副作用]]是會引起[[消化不良|胃部不適]]<ref name=AHSF2016/>。更嚴重的副作用則包含[[胃及十二指肠潰瘍|胃潰瘍]]、[[胃出血|胃出血]]等等，也可能會使[[哮喘|氣喘]]惡化<ref name=AHSF2016/>。其中年長者、[[酗酒|酗酒]]者，以及還有服用其他[[非甾体抗炎药|非甾体抗炎药]]或[[抗凝剂|抗凝剂]]者，出血風險更高<ref name=AHSF2016/>，[[妊娠|妊娠]]後期也不建議用藥<ref name=AHSF2016/>。有[[感染|感染]]的孩童不建議用藥，因为这会增加患[[瑞氏综合征|瑞氏综合征]]的风险<ref name=AHSF2016/>。高劑量者可能會引起[[耳鸣|耳鸣]]<ref name=AHSF2016/>。

<!-- Mechanism of action -->
虽然它们都有名为水杨酸的类似[[分子结构|结构]]，作用相似（解热、消炎、镇痛），抑制的[[环氧化酶|环氧化酶]]（COX）也相同，但阿司匹林的不同之处在于其抑制作用[[酶抑制剂|不可逆]]，而且对环氧化酶-1（COX-1）的抑制作用比对环氧化酶-2的（COX-2）更强<ref name="Goodman and Gilman's">{{Cite book |last=Burke |first=Anne |last2=Smyth |first2=Emer |last3=FitzGerald |first3=Garret A. |chapter=26: Analgesic Antipyretic and Antiinflammatory Agents |title={{le|Goodman & Gilman's The Pharmacological Basis of Therapeutics}} |editor1-first=Laurence L. |editor1-last=Brunton |editor2-first=John S. |editor2-last=Lazo |editor3-first=Keith |editor3-last=Parker |publisher=McGraw-Hill |year=2006 |edition=11 |isbn=978-0-07-142280-2 |location=New York |pages=671–716}}</ref>。

<!-- History -->
阿司匹林衍生自[[柳树|柳树]]皮中发现的化学物质。早在2400年前柳树皮就用来治病，[[古希臘|古希臘]]醫師[[希波克拉底|希波克拉底]]就用它来治头痛<ref name=Jon2015>{{cite book|last1=Jones|first1=Alan|title=Chemistry: An Introduction for Medical and Health Sciences|date=2015|publisher=John Wiley & Sons|isbn=9780470092903|pages=5–6|url=https://books.google.com/books?id=ubE0ILq_aDQC&pg=PA6|language=en}}</ref><ref>{{cite book|last1=Ravina|first1=Enrique|title=The Evolution of Drug Discovery: From Traditional Medicines to Modern Drugs|date=2011|publisher=John Wiley & Sons|isbn=9783527326693|page=24|url=https://books.google.ca/books?id=iDNy0XxGqT8C&pg=PA24|language=en|access-date=2018-01-22|archive-url=https://web.archive.org/web/20171201033149/https://books.google.ca/books?id=iDNy0XxGqT8C&pg=PA24|archive-date=2017-12-01|dead-url=no}}</ref>。1763年，在[[牛津大学|牛津大学]]的[[沃德姆学院|沃德姆学院]]，{{link-en|爱德华·斯通|Edward Stone (clergyman)}}首次从柳树皮中发现了阿司匹林的有效成分水杨酸<ref>{{cite journal |author=Stone Edmund |title=An Account of the Success of the Bark of the Willow in the Cure of Agues. In a Letter to the Right Honourable George Earl of Macclesfield, President of R. S. from the Rev. Mr. Edmund Stone, of Chipping-Norton in Oxfordshire |journal=Philosophical Transactions of the Royal Society of London |volume=53 |pages=195–200 |year=1763 |url=http://books.google.com/books?id=j0JFAAAAcAAJ&pg=PA195#v=onepage&q&f=false |jstor=105721 |doi=10.1098/rstl.1763.0033 |access-date=2015-06-05 |archive-date=2015-07-13 |archive-url=https://web.archive.org/web/20150713190512/https://books.google.com/books?id=j0JFAAAAcAAJ&pg=PA195#v=onepage&q&f=false |dead-url=no }}</ref>。1853年，法國化學家{{tsl|en|Charles Frédéric Gerhardt|查爾斯·弗雷德里克·格哈特}}將[[水杨酸钠|水杨酸钠]]以[[乙酰氯|乙酰氯]]處理，首次合成出乙醯水楊酸<ref name=Jeffreys2008>{{cite book|last1=Jeffreys|first1=Diarmuid|title=Aspirin the remarkable story of a wonder drug.|date=2008|publisher=Bloomsbury Publishing USA|isbn=9781596918160|url=https://books.google.com/books?id=a9gkBwAAQBAJ&dq|deadurl=no|archiveurl=https://web.archive.org/web/20170908213430/https://books.google.com/books?id=a9gkBwAAQBAJ&dq|archivedate=2017-09-08}}{{rp|46–48}}</ref>。此後五十年，化學家們逐步提升生產的效率<ref name=Jeffreys2008/>{{rp|69–75}}。1897年，[[德国|德国]][[拜耳|拜耳]]開始研究乙醯水楊酸的醫療用途，以代替高刺激性的水楊酸類藥物<ref name=Jeffreys2008/>{{rp|69–75}}。到1899年，拜耳以阿司匹林（Aspirin）為[[商標|商標]]，將本品銷售至全球<ref name=MannPlummer1991>{{cite book|last1=Mann|first1=Charles C.|last2=Plummer|first2=Mark L.|title=The aspirin wars : money, medicine, and 100 years of rampant competition|url=https://archive.org/details/aspirinwarsmoney0000mann|date=1991|publisher=Knopf|location=New York|isbn=0-394-57894-5|page=[https://archive.org/details/aspirinwarsmoney0000mann/page/27 27]|edition=1st}}</ref>。此後五十年，阿斯匹靈躍升成為使用最廣泛的藥物之一<ref name="ACS">{{cite web |url=http://pubs.acs.org/cen/coverstory/83/8325/8325aspirin.html |title=Aspirin |accessdate=2007-08-13 |work=Chemical & Engineering News |archive-date=2008-10-11 |archive-url=https://web.archive.org/web/20081011091220/http://pubs.acs.org/cen/coverstory/83/8325/8325aspirin.html |dead-url=no }}</ref>。目前，拜耳公司在很多國家對於「阿司匹靈」一名的專利權已經過期，或是已經賣給其他公司<ref name=ACS/>。

<!-- Society and cost -->
本品是当今世界上应用最广泛的药物之一，每年的消费量约40,000[[公噸|公噸]]（約500至1200億[[片剂|錠]]）<ref name=Jon2015/><ref name="COX2002">{{Cite journal |title=Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum? |journal=Proceedings of the National Academy of Sciences of the United States of America|year=2002|author2=Warner TD, Mitchell JA|volume=99|issue=21|pages=13371–3|pmid=12374850|author=Warner, T D|pmc=129677|doi=10.1073/pnas.222543099|bibcode=2002PNAS...9913371W}}</ref>。本品列名於[[世界卫生组织基本药物标准清单|世界卫生组织基本药物标准清单]]之中，為基礎公衛體系必備藥物之一<ref name=WHO19th>{{cite web|title=WHO Model List of Essential Medicines (19th List)|url=http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|work=World Health Organization|accessdate=2016-12-08|date=April 2015|deadurl=no|archiveurl=https://web.archive.org/web/20161213052708/http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|archivedate=2016-12-13}}</ref>。本品屬於[[通用名药物|學名藥]]<ref name=AHSF2016/>，{{As of|2014}}，每劑在[[发展中国家|发展中国家]]的[[批發|批發價]]約介於0.002至0.025[[美元|美元]]之間<ref>{{cite web|title=Acetylsalicylic Acid|url=http://mshpriceguide.org/en/single-drug-information/?DMFId=3&searchYear=2014|website=International Drug Price Indicator Guide|accessdate=2016-08-30|archive-url=https://web.archive.org/web/20180122072358/http://mshpriceguide.org/en/single-drug-information/?DMFId=3&searchYear=2014|archive-date=2018-01-22|dead-url=no}}</ref>。{{As of|2015}}，每月劑量在[[美國|美國]]的價格低於25.00美金<ref name=Ric2015>{{cite book|last1=Hamilton|first1=Richart|title=Tarascon pocket pharmacopoeia |edition=2015 deluxe lab-coat|date=2015|publisher=Jones & Bartlett Learning|isbn=9781284057560|page=5}}</ref>。
{{TOC limit|3}}

== 医疗用途 ==
阿司匹林可以治疗多种疾病，包括[[发烧|发烧]]、[[疼痛|疼痛]]、[[风湿热|风湿热]]，也可治疗一些炎症，如[[类风湿性关节炎|类风湿性关节炎]]、[[心包炎|心包炎]]和[[川崎病|川崎病]]<ref name=AHFS>{{cite web|title=Aspirin|url=http://www.drugs.com/monograph/aspirin.html|publisher=The American Society of Health-System Pharmacists|accessdate=2011-04-03|deadurl=no|archiveurl=https://web.archive.org/web/20110101134001/http://www.drugs.com/monograph/aspirin.html|archivedate=2011-01-01}}</ref>。低剂量服用还可减少[[心肌梗塞|心肌梗塞]]发作的死亡风险，某些情况下也可减少发生[[中风|中风]]的风险<ref name="USFDA-patient-guideline">{{cite web |title=Aspirin for reducing your risk of heart attack and stroke: know the facts |url=http://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/UnderstandingOver-the-CounterMedicines/SafeDailyUseofAspirin/ucm291433.htm |publisher=U.S. Food and Drug Administration |accessdate=2012-07-26 |deadurl=no |archiveurl=https://web.archive.org/web/20120814182151/http://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/UnderstandingOver-the-CounterMedicines/SafeDailyUseofAspirin/ucm291433.htm |archivedate=2012-08-14 }}</ref><ref name="USPSTF-CV">{{cite web |title=Aspirin for the prevention of cardiovascular disease |url=http://www.uspreventiveservicestaskforce.org/uspstf/uspsasmi.htm |publisher={{tsl|en|U.S. Preventive Services Task Force||U.S. Preventive Services Task Force}} |accessdate=2012-07-26 |deadurl=yes |archiveurl=https://web.archive.org/web/20120711031337/http://www.uspreventiveservicestaskforce.org/uspstf/uspsasmi.htm |archivedate=2012-07-11 }}</ref><ref>{{cite journal|last1=Seshasai|first1=SR|author2=Wijesuriya, S |author3=Sivakumaran, R |author4=Nethercott, S |author5=Erqou, S |author6=Sattar, N |author7=Ray, KK|title=Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials|journal={{tsl|en|Archives of Internal Medicine||Archives of Internal Medicine}}|date=2012-02-13|volume=172|issue=3|pages=209–16|pmid=22231610|doi=10.1001/archinternmed.2011.628}}</ref>。部分证据表明阿司匹林可以预防[[直肠癌|直肠癌]]，但是其原理尚不明晰<ref name="Algra 518–27">{{cite journal|last1=Algra|first1=AM|author2=Rothwell, PM|title=Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials|journal=[[柳葉刀_(雜誌)|The Lancet Oncology]]|date=May 2012|volume=13|issue=5|pages=518–27|pmid=22440112|doi=10.1016/S1470-2045(12)70112-2}}</ref>。在美國，50歲至70歲的人且心血管疾病風險大於10%的族群可給予低劑量阿斯匹靈，且不會增加出血風險<ref>{{cite journal|last1=Bibbins-Domingo|first1=K|last2=U.S. Preventive Services Task|first2=Force|title=Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S. Preventive Services Task Force recommendation statement|journal={{tsl|en|Annals of Internal Medicine||Annals of Internal Medicine}} |date=2016-06-21|volume=164|issue=12|pages=836–45|pmid=27064677|doi=10.7326/m16-0577}}</ref>。

===疼痛===
[[File:Aspirin1.jpg|right]]
[[File:Aspirine_macro_shot.jpg|thumb]]
对急性疼痛而言，阿司匹林是一种高效的镇痛药，但是通常认为其对疼痛的缓解效果不如[[布洛芬|布洛芬]]，因为阿司匹林更容易引发[[胃肠道出血|胃肠道出血]]<ref name=pmid15768621>{{cite journal | last1 = Sachs | first1 = CJ | title = Oral analgesics for acute nonspecific pain | journal = {{tsl|en|American Family Physician||American Family Physician}} | volume = 71 | issue = 5 | pages = 913–918 | year = 2005 | pmid = 15768621 | url = http://www.aafp.org/afp/2005/0301/p913.html | deadurl = no | archiveurl = https://web.archive.org/web/20140528051101/http://www.aafp.org/afp/2005/0301/p913.html | archivedate = 2014-05-28 | access-date = 2015-06-06 }}</ref>。 一般情况下，阿司匹林对肌肉[[抽搐|抽搐]]、[[腹胀|腹胀]]、{{link-en|胃扩张|gastric distension}}和急性皮肤刺激引起的疼痛无明显效果<ref name=pmid14592563>{{cite journal | title = The real dimension of analgesic activity of aspirin | journal = {{tsl|en|Thrombosis Research||Thrombosis Research}} | volume = 110 | issue = 5–6 | pages = 361–364 | year = 2003 | pmid = 14592563 | doi = 10.1016/j.thromres.2003.08.009 | author1 = Gaciong }}</ref>。像其他[[非甾体抗炎药|非甾体抗炎药]]一样，阿司匹林与[[檸檬酸咖啡因|檸檬酸咖啡因]]一起使用的止痛效果比单独使用阿司匹林要好<ref name=pmid22419343>{{cite journal | last1 = Derry | first1 = CJ | last2 = Derry | first2 = S | last3 = Moore | first3 = RA | journal = [[考科藍|Cochrane Database of Systematic Reviews]] | volume = 3 | issue = 3 | pages = CD009281 | year = 2012 | pmid = 22419343 | doi = 10.1002/14651858.CD009281.pub2 | title = Caffeine as an analgesic adjuvant for acute pain in adults | editor1-first = Sheena | editor1-last = Derry }}</ref>。阿司匹林[[泡腾片|泡腾片]]，如白加黑或拜阿司匹林<ref name="USFDA Blowfish">{{cite web|title=Blowfish (aspirin, caffeine) tablet, effervescent [Rally Labs LLC]|url=http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0d3798bc-04ef-584e-821b-7aa76036b7d1|work=DailyMed|publisher=U.S. Federal Drug Administration|accessdate=2012-07-27|deadurl=no|archiveurl=https://web.archive.org/web/20130228143215/http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0d3798bc-04ef-584e-821b-7aa76036b7d1|archivedate=2013-02-28}}</ref>，比药片起效更快<ref name=pmid10868553>{{cite journal | last1 = Hersh | first1 = E | last2 = Moore | first2 = P | last3 = Ross | first3 = G | title = Over-the-counter analgesics and antipyretics: A critical assessment | journal = {{tsl|en|Clinical Therapeutics||Clinical Therapeutics}} | volume = 22 | issue = 5 | pages = 500–548 | year = 2000 | pmid = 10868553 | doi = 10.1016/S0149-2918(00)80043-0 }}</ref>，可以有效治疗[[偏头痛|偏头痛]]<ref name=pmid18451718>{{cite journal | last1 = Mett | first1 = A | last2 = Tfelt-Hansen | first2 = P | title = Acute migraine therapy: recent evidence from randomized comparative trials | journal = {{tsl|en|Current Opinion in Neurology||Current Opinion in Neurology}} | volume = 21 | issue = 3 | pages = 331–337 | year = 2008 | pmid = 18451718 | pmc =  | doi = 10.1097/WCO.0b013e3282fee843 }}</ref>。可以有效地治疗某些形式的[[神经性疼痛|神经性疼痛]]<ref>{{cite journal|last=Kingery|first=WS|title=A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes|journal={{tsl|en|Pain (journal)||Pain}} |date=November 1997|volume=73|issue=2|pages=123–39|pmid=9415498|doi=10.1016/S0304-3959(97)00049-3}}</ref>。

====头痛====
阿司匹林及其复方制剂都能有效治疗某几种[[头痛|头痛]]，但对另外几种则效果不明。因其他疾病或创伤导致的继发性头痛需要及时在医疗机构接受治疗。

{{link-en|国际头痛分类标准|International Classification of Headache Disorders}}（ICHD）把原发性头痛分为{{link-en|紧张性头痛|tension headache}}、[[偏头痛|偏头痛]]和[[丛集性头痛|丛集性头痛]]等类别。普遍{{Who}}认为包括阿司匹林在内的非处方止痛药可以有效治疗紧张性头痛<ref>{{cite journal|last1=Loder|first1=E|author2=Rizzoli, P|title=Tension-type headache|journal=[[The_BMJ|BMJ (Clinical research ed.)]]|date=2008-01-12 | volume=336 | issue=7635 | pages=88–92 | pmid=18187725 | doi=10.1136/bmj.39412.705868.AD|pmc=2190284}}</ref>。

阿司匹林，特别是和[[对乙酰氨基酚|对乙酰氨基酚]]、[[咖啡因|咖啡因]]组成复方药物（如阿咖酚散），被认为是治疗偏头痛的首选，在疼痛刚发作时最有效，药效相当于服用低剂量的[[舒马曲坦|舒马曲坦]]<ref>{{cite journal|last1=Gilmore|first1=B|author2=Michael, M|title=Treatment of acute migraine headache|journal=American family physician|date=2011-02-01|volume=83|issue=3|pages=271–80|pmid=21302868}}</ref>。

===炎症与发热===
阿司匹林可以不可逆地抑制[[环氧化酶|环氧化酶]]（COX）来调节[[前列腺素|前列腺素]]系统，進而達到疼痛控制及退燒的效果<ref>{{cite journal|last1=Bartfai|first1=T|author2=Conti, B|title=Fever|journal={{tsl|en|The Scientific World Journal||The Scientific World Journal}}|date=2010-03-16|volume=10|pages=490–503|doi=10.1100/tsw.2010.50|pmid=20305990|pmc=2850202}}</ref>。也可以治疗某些急性或慢性的发炎性疾病<ref>{{cite journal |authors=Thea Morris, Melanie Stables, Adrian Hobbs, Patricia de Souza, Paul Colville-Nash, Tim Warner, Justine Newson, Geoffrey Bellingan, and Derek W. Gilroy  |title=Effects of low-dose aspirin on acute inflammatory responses in humans |journal={{tsl|en|Journal of Immunology||Journal of Immunology}} |volume=183 |issue=3 |pages=2089–2096 |date=2009-08-01 |pmid=19597002 |doi=10.4049/jimmunol.0900477 }}</ref>，如[[类风湿性关节炎|类风湿性关节炎]]<ref name=AHFS />。阿司匹林是一种公认的成人用[[退烧药|退烧药]]，但许多医学协会（包含{{tsl|en|American Academy of Family Physicians|美國家庭醫學會}}、[[美國兒科學會|美國兒科學會]]，以及[[美国食品药品监督管理局|美国食品药品监督管理局]]）及监管机构强烈反对用它治疗儿童发热，因为儿童在有病毒或细菌感染时使用水杨酸类药物可能会患上[[瑞氏综合征|瑞氏综合征]]，患病几率虽小，但致死率很高<ref>{{cite journal|last1=Pugliese|first1=A|author2=Beltramo, T |author3=Torre, D|title=Reye's and Reye's-like syndromes|journal=Cell biochemistry and function|date=October 2008|volume=26|issue=7|pages=741–6|pmid=18711704|doi=10.1002/cbf.1465}}</ref><ref>{{cite journal|last1=Beutler|first1=AI|author2=Chesnut, GT |author3=Mattingly, JC |author4=Jamieson, B|title=FPIN's Clinical Inquiries. Aspirin use in children for fever or viral syndromes|journal=American Family Physician|date=2009-12-15|volume=80|issue=12|page=1472|pmid=20000310}}</ref><ref name=AAPweb>{{cite web|title=Medications Used to Treat Fever|url=http://www.healthychildren.org/English/health-issues/conditions/fever/Pages/Medications-Used-to-Treat-Fever.aspx|publisher=American Academy of Pediatrics|accessdate=2012-11-25|deadurl=no|archiveurl=https://web.archive.org/web/20130218084054/http://www.healthychildren.org/English/health-issues/conditions/fever/Pages/Medications-Used-to-Treat-Fever.aspx|archivedate=2013-02-18}}</ref>。鉴于这一风险，[[美国食品药品监督管理局|美国食品药品监督管理局]]（FDA）从1986年开始要求所有含阿司匹林的药物都需注明儿童和青少年不宜服用<ref name="FDA 1986 FR">{{cite journal|title=51 FR 8180|url=http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/DevelopmentResources/Over-the-CounterOTCDrugs/StatusofOTCRulemakings/UCM078593.pdf|journal=United States Federal Register|volume=51|issue=45|date=1986-03-07|accessdate=2012-11-25|deadurl=no|archiveurl=https://web.archive.org/web/20110819130409/http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/DevelopmentResources/Over-the-CounterOTCDrugs/StatusofOTCRulemakings/UCM078593.pdf|archivedate=2011-08-19}}</ref>。

===心脏病和中风===
1970年初，牛津大学心血管内科的名誉教授{{link-en|彼得·斯莱特|Peter Sleight}}研究了阿司匹林对心脏功能的影响和预防中风的效果<ref>{{cite web |url=http://www.prnewswire.com/news-releases/research-confirms-and-points-to-future-aspirin-uses-for-disease-prevention-75958547.html |title=Research Confirms and Points to Future Aspirin Uses For Disease Prevention – re> BERLIN, Dec. 1 /PRNewswire/ |publisher=Prnewswire.com |date= |accessdate=2014-05-05 |archive-url=https://web.archive.org/web/20140327144401/http://www.prnewswire.com/news-releases/research-confirms-and-points-to-future-aspirin-uses-for-disease-prevention-75958547.html |archive-date=2014-03-27 |dead-url=yes }}</ref>。斯莱特和他的团队为研究该药用于防治其他疾病打下基础。一份2015的报告指出，50岁的心脏病高危人群每日服用低剂量阿司匹林获益最大<ref>{{cite web | url=http://www.drugs.com/news/their-50s-benefit-most-low-aspirin-report-says-58263.html | title=People in Their 50s Benefit Most From Low-Dose Aspirin, Report Says | accessdate=2015-09-24 | archive-url=https://web.archive.org/web/20150925112058/http://www.drugs.com/news/their-50s-benefit-most-low-aspirin-report-says-58263.html | archive-date=2015-09-25 | dead-url=yes }}</ref>。

阿斯匹靈在[[心肌梗死|心肌梗死]]的治療上面扮演重要的角色<ref>{{cite journal |title=Myocardial infarction with ST-segment elevation: the acute management of myocardial infarction with ST-segment elevation [Internet] |journal=NICE Clinical Guidelines |issue=167 |date=July 2013 |at=17.2 Asprin |url=https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0071000/# |pmid=25340241 |deadurl=no |archiveurl=https://web.archive.org/web/20151231192814/http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0071000/ |archivedate=2015-12-31 |access-date=2018-01-23 }}</ref>。一項臨床研究發現在懷疑有[[心肌梗死|ST段上升心肌梗塞]]（STEMI）的患者，阿斯匹靈能夠將30日死亡率從11.8%降低至9.4%<ref name=Qu2009/>。在這些患者中，大出血的風險不會因為服藥增加，但小出血的風險會上升<ref name=Qu2009>{{cite web |last1=Quaas |first1=Joshua |title=Aspirin given immediately for a major heart attack (STEMI) |publisher=The NNT |url=http://www.thennt.com/nnt/aspirin-for-major-heart-attack/ |accessdate=2016-08-10 |date=2009-11-28 |deadurl=no |archiveurl=https://web.archive.org/web/20160809181554/http://www.thennt.com/nnt/aspirin-for-major-heart-attack/ |archivedate=2016-08-09 }}</ref>。

阿司匹林能够[[预防|预防]]高心血管風險的人群發生心脏病和中风的機會，低剂量服用时能延缓心血管疾病的进程，降低有病史的人群的复发率（即“次級预防”）<ref name=pmid20112887>{{cite journal|last1=Hall|first1=SL|author2=Lorenc, T|title=Secondary prevention of coronary artery disease|journal=American family physician|date=2010-02-01|volume=81|issue=3|pages=289–96|pmid=20112887}}</ref><ref name="pmid19482214">{{cite journal |last1=Baigent |first1=C |last2=Blackwell |first2=L |last3=Collins |first3=R |last4=Emberson |first4=J |last5=Godwin |first5=J |last6=Peto |first6=R |last7=Buring |first7=J |last8=Hennekens |first8=C |last9=Kearney |first9=P |last10=Meade |first10=T |last11=Patrono |first11=C |last12=Roncaglioni |first12=MC |last13=Zanchetti |first13=A |title=Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials |journal=Lancet |volume=373 |issue=9678 |pages=1849–60 |year=2009 |pmid=19482214 |pmc=2715005 |doi=10.1016/S0140-6736(09)60503-1}}</ref>。目前研究顯示在高心血管風險的族群，合併使用{{Le|利伐沙班|Rivaroxaban}}可以提升預防心血管事件的效果，但同時出血風險也會增加<ref>{{Cite journal|title=Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease|url=https://doi.org/10.1056/NEJMoa1709118|last=Eikelboom|first=John W.|last2=Connolly|first2=Stuart J.|date=2017-10-05|journal=New England Journal of Medicine|issue=14|doi=10.1056/NEJMoa1709118|volume=377|pages=1319–1330|issn=0028-4793|pmid=28844192|last3=Bosch|first3=Jackie|last4=Dagenais|first4=Gilles R.|last5=Hart|first5=Robert G.|last6=Shestakovska|first6=Olga|last7=Diaz|first7=Rafael|last8=Alings|first8=Marco|last9=Lonn|first9=Eva M.|access-date=2019-01-06|archive-date=2019-07-13|archive-url=https://web.archive.org/web/20190713075907/https://www.nejm.org/doi/10.1056/NEJMoa1709118|dead-url=no}}</ref>。不过预防性服用阿司匹林对低风险人群（如没有心脏病和中风病史，没有基础性疾病的人）並沒有益處，研究還顯示可能增加重大出血和癌症死亡的風險<ref name="Guirguis2016">{{cite journal|title=Aspirin for Primary Prevention|first1=IB|last2=Owens|first2=DK|date=July 2017|journal=The Medical Clinics of North America|issue=4|doi=10.1016/j.mcna.2017.03.004|volume=101|page=713-24|type=Review|pmid=28577622|last1=Richman}}</ref><ref>{{Cite journal|title=Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly|author=|url=https://doi.org/10.1056/NEJMoa1805819|last=McNeil|first=John J.|last2=Wolfe|first2=Rory|date=2018-10-18|journal=New England Journal of Medicine|issue=16|doi=10.1056/NEJMoa1805819|others=|year=|volume=379|page=|pages=1509–1518|issn=0028-4793|pmc=6289056|pmid=30221597|last3=Woods|first3=Robyn L.|last4=Tonkin|first4=Andrew M.|last5=Donnan|first5=Geoffrey A.|last6=Nelson|first6=Mark R.|last7=Reid|first7=Christopher M.|last8=Lockery|first8=Jessica E.|last9=Kirpach|first9=Brenda|access-date=2019-01-06|archive-date=2019-07-13|archive-url=https://web.archive.org/web/20190713075908/https://www.nejm.org/doi/10.1056/NEJMoa1805819|dead-url=no}}</ref>。

预防性服用阿司匹林的另一问题是会产生耐药现象<ref name="pmid16364973">{{cite journal|last1=Wang|first1=TH|author2=Bhatt, DL; Topol, EJ|title=Aspirin and clopidogrel resistance: an emerging clinical entity|journal=European heart journal|date=March 2006|volume=27|issue=6|pages=647–54|pmid=16364973|doi=10.1093/eurheartj/ehi684}}</ref><ref name="pmid20944898">{{cite journal|last1=Oliveira|first1=DC|author2=Silva, RF; Silva, DJ; Lima, VC|title=Aspirin resistance: fact or fiction?|journal=Arquivos brasileiros de cardiologia|date=September 2010|volume=95|issue=3|pages=e91–4|pmid=20944898|doi=10.1590/S0066-782X2010001300024}}</ref>。如果患者有耐药性，药物的效力就会下降，这会增加中风的风险<ref name="pmid21306212">{{cite journal|last1=Topçuoglu|first1=MA|author2=Arsava, EM; Ay, H|title=Antiplatelet resistance in stroke|journal=Expert Review of Neurotherapeutics|date=February 2011|volume=11|issue=2|pages=251–63|pmid=21306212|doi=10.1586/ern.10.203|pmc=3086673}}</ref>。 有醫学家建议对治疗方案进行测试，以确定哪些患者对阿司匹林和其他抗血栓药（如[[氯吡格雷|氯吡格雷]]）有耐药性<ref name="pmid19576352">{{cite journal|last1=Ben-Dor|first1=I|author2=Kleiman, NS; Lev, E|title=Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy|journal=The American journal of cardiology|date=2009-07-15|volume=104|issue=2|pages=227–33|pmid=19576352|doi=10.1016/j.amjcard.2009.03.022}}</ref>。

也有醫学家建议含阿司匹林的[[复方制剂|复方制剂]]用于预防心血管疾病<ref name="pmid16100022">{{cite journal|last=Norris|first=JW|title=Antiplatelet agents in secondary prevention of stroke: a perspective|journal=Stroke; a journal of cerebral circulation|date=September 2005|volume=36|issue=9|pages=2034–6|pmid=16100022|doi=10.1161/01.STR.0000177887.14339.46}}</ref><ref name="pmid16603580">{{cite journal|last1=Sleight|first1=P|author2=Pouleur, H; Zannad, F|title=Benefits, challenges, and registerability of the polypill|journal=European heart journal|date=July 2006|volume=27|issue=14|pages=1651–6|pmid=16603580|doi=10.1093/eurheartj/ehi841}}</ref>。

===术后===
美国{{link-en|卫生保健研究和质量监督局|Agency for Healthcare Research and Quality}}（AHRQ）在一份指南中建议，完成[[冠状动脉再成形术|冠状动脉再成形术]]（PCI），例如安装[[冠状动脉|冠状动脉]][[支架|支架]]后，应终身服用阿司匹林。<ref>{{cite web|last=National Guideline Clearinghouse (NGC)|title=2011 ACCF/AHA/SCAI guideline for percutaneous coronary artery intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.|url=http://www.guideline.gov/content.aspx?id=34980|publisher=United States Agency for Healthcare Research and Quality (AHRQ)|accessdate=2012-08-28|archive-url=https://web.archive.org/web/20120813064712/http://www.guideline.gov/content.aspx?id=34980|archive-date=2012-08-13|dead-url=yes}}</ref> 该药常与{{link-en|ADP受体拮抗剂|ADP receptor inhibitor}}（如[[奥格列汀|奥格列汀]]、[[普拉格雷|普拉格雷]]、[[替格瑞洛|替格瑞洛]]等）联用以预防[[血栓|血栓]]，这种疗法叫做“双重抗血栓疗法”（DAPT）。美国和欧盟对术后采用疗法有不同的方针。美国建议DAPT治疗至少持续12个月，而欧盟则建议根据不同情况持续治疗1至12个月不等。<ref>{{cite journal|last1=Musumeci|first1=G|author2=Di Lorenzo, E; Valgimigli, M|title=Dual antiplatelet therapy duration: what are the drivers?|journal=Current Opinion in Cardiology|date=December 2011|volume=26 Suppl 1|pages=S4–14|pmid=22129582|doi=10.1097/01.hco.0000409959.11246.ba}}</ref>

===预防癌症===
阿司匹林能降低[[癌症|癌症]]<ref name=Cuz2014>{{cite journal|last1=Cuzick|first1=J|last2=Thorat|first2=MA|last3=Bosetti|first3=C|last4=Brown|first4=PH|last5=Burn|first5=J|last6=Cook|first6=NR|last7=Ford|first7=LG|last8=Jacobs|first8=EJ|last9=Jankowski|first9=JA|last10=La Vecchia|first10=C|last11=Law|first11=M|last12=Meyskens|first12=F|last13=Rothwell|first13=PM|last14=Senn|first14=HJ|last15=Umar|first15=A|title=Estimates of benefits and harms of prophylactic use of aspirin in the general population.|journal=Annals of oncology : official journal of the European Society for Medical Oncology / ESMO|date=2014-08-05|pmid=25096604|doi=10.1093/annonc/mdu225|volume=26|pages=47–57}}</ref>，特别是[[大肠癌|大肠癌]]（CRC）<ref name="Algra 518–27"/><ref>{{cite journal|last1=Manzano|first1=A|author2=Pérez-Segura, P|title=Colorectal cancer chemoprevention: is this the future of colorectal cancer prevention?|journal=TheScientificWorldJournal|year=2012|volume=2012|page=327341|doi=10.1100/2012/327341|pmid=22649288|pmc=3353298}}</ref><ref>{{cite journal|last1=Chan|first1=AT|author2=Arber, N; Burn, J; Chia, WK; Elwood, P; Hull, MA; Logan, RF; Rothwell, PM; Schrör, K; Baron, JA|title=Aspirin in the chemoprevention of colorectal neoplasia: an overview|journal=Cancer prevention research (Philadelphia, Pa.)|date=February 2012|volume=5|issue=2|pages=164–78|pmid=22084361|doi=10.1158/1940-6207.CAPR-11-0391|pmc=3273592}}</ref><ref>{{cite journal|last1=Thun|first1=MJ|author2=Jacobs, EJ; Patrono, C|title=The role of aspirin in cancer prevention|journal=Nature Reviews Clinical Oncology|date=2012-04-03|volume=9|issue=5|pages=259–67|pmid=22473097|doi=10.1038/nrclinonc.2011.199}}</ref> 的发生率和死亡率。但效果需要服藥至少10至20年才能見到效果<ref name="Richman2017">{{cite journal|title=Aspirin for Primary Prevention|first1=IB|last2=Owens|first2=DK|date=July 2017|journal=The Medical Clinics of North America|issue=4|doi=10.1016/j.mcna.2017.03.004|volume=101|page=713-24|type=Review|pmid=28577622|last1=Richman}}</ref>。此外，本品也能減少[[陰道癌|陰道癌]]<ref>{{Cite journal|title=Non-steroidal anti-inflammatory drug use and risk of endometrial cancer: A systematic review and meta-analysis of observational studies|url=http://linkinghub.elsevier.com/retrieve/pii/S0090825815302134|last=Verdoodt|first=Freija|last2=Friis|first2=Søren|journal=Gynecologic Oncology|issue=2|doi=10.1016/j.ygyno.2015.12.009|volume=140|pages=352–358|last3=Dehlendorff|first3=Christian|last4=Albieri|first4=Vanna|last5=Kjaer|first5=Susanne K.|author=|access-date=2018-01-22|archive-url=https://web.archive.org/web/20180123072218/http://linkinghub.elsevier.com/retrieve/pii/S0090825815302134|archive-date=2018-01-23|dead-url=no}}</ref>、[[乳癌|乳癌]]，以及[[前列腺癌|前列腺癌]]<ref>{{cite journal|title=Aspirin and cancer risk: a quantitative review to 2011|first1=C|last2=Rosato|first2=V|date=2012-04-19|journal={{tsl|en|Annals of Oncology||Annals of Oncology}}|issue=6|doi=10.1093/annonc/mds113|volume=23|pages=1403–1415|pmid=22517822|last3=Gallus|first3=S|last4=Cuzick|first4=J|last5=La Vecchia|first5=C|last1=Bosetti}}</ref>的風險。

有些醫学家认为，对患癌风险一般的人而言，若把阿司匹林的防癌作用和引起出血的风险相比，利大于弊，<ref name=Cuz2014/> 但还有些醫学家不太确定是否如此<ref>{{cite journal|title=Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews.|first1=P|last2=Connock|first2=M|date=Sep 2013|journal=Health technology assessment (Winchester, England)|issue=43|doi=10.3310/hta17430|volume=17|pages=1–253|pmid=24074752|last3=Gurung|first3=T|last4=Freeman|first4=K|last5=Johnson|first5=S|last6=Kandala|first6=NB|last7=Grove|first7=A|last8=Gurung|first8=B|last9=Morrow|first9=S|last1=Sutcliffe|last10=Clarke|first10=A}}</ref><ref>{{cite journal|title=The benefit-risk consideration in long-term use of alternate-day, low dose aspirin: focus on colorectal cancer prevention.|first1=SE|date=2014|journal=Annals of gastroenterology : quarterly publication of the Hellenic Society of Gastroenterology|issue=1|volume=27|pages=87–88|pmid=24714632|last1=Kim}}</ref>。由于这种不确定性，美国{{link-en|预防服务工作组|United States Preventive Services Task Force}}（USPSTF）在有关这个问题的指南中不建议患癌风险一般的人群服用阿司匹林预防大肠癌。<ref>{{cite journal|title=Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: U.S. Preventive Services Task Force recommendation statement|last=U.S. Preventive Services Task|first=Force|date=2007-03-06|journal=Annals of Internal Medicine|issue=5|doi=10.7326/0003-4819-146-5-200703060-00008|volume=146|pages=361–4|pmid=17339621}}</ref>

=== 其他 ===
阿司匹林是治疗急性[[风湿热|风湿热]]所引起的发热和关节痛的一线药物。这种疗法的疗程通常为一两星期，一般不会更长。发热和疼痛缓解后就不用再服药了，因为它不能减少心脏并发症和风湿性心脏瓣膜病后遗症的发生率。<ref name=NHFA>{{cite web |url=http://www.racgp.org.au/Content/NavigationMenu/ClinicalResources/RACGPGuidelines/DiagnosisandmanagementofacuterheumaticfeverandrheumaticheartdiseaseinAustralia/NHFA-CSANZ_ARF_RHD_2006.pdf |archiveurl=https://web.archive.org/web/20080726052030/http://www.racgp.org.au/Content/NavigationMenu/ClinicalResources/RACGPGuidelines/DiagnosisandmanagementofacuterheumaticfeverandrheumaticheartdiseaseinAustralia/NHFA-CSANZ_ARF_RHD_2006.pdf |archivedate=2008-07-26 |title=Diagnosis and management of acute rheumatic fever and rheumatic heart disease in Australia. An evidence-based review |author=National Heart Foundation of Australia (RF/RHD guideline development working group) and the Cardiac Society of Australia and New Zealand |year=2006 |format=PDF |publisher=National Heart Foundation of Australia |pages=33–37 |accessdate=2011-05-09 |dead-url=yes }}</ref><ref>{{cite journal |last1=Working Group on Pediatric Acute Rheumatic Fever and Cardiology Chapter of Indian Academy of |first1=Pediatrics|author2=Saxena, A; Kumar, RK; Gera, RP; Radhakrishnan, S; Mishra, S; Ahmed, Z|title=Consensus guidelines on pediatric acute rheumatic fever and rheumatic heart disease|journal=Indian pediatrics|date=July 2008|volume=45|issue=7|pages=565–73|pmid=18695275}}</ref> [[萘普生|萘普生]]的药效和阿司匹林相当，毒性更小，但由于临床使用经验有限，建议该药仅用作二线治疗。<ref name=NHFA/><ref>{{cite journal | last2 = Tauber | first2 = T. | last3 = Somekh | first3 = E. | last4 = Brik | first4 = R. | last5 = Barash | first5 = J. | last6 = Mukamel | first6 = M. | last7 = Harel | first7 = L. | last8 = Lorber | first8 = A. | last9 = Berkovitch | first9 = M. | last10 = Uziel | first10 = Y. | title = Naproxen as an alternative to aspirin for the treatment of arthritis of rheumatic fever: a randomized trial | url = https://archive.org/details/sim_journal-of-pediatrics_2003-09_143_3/page/399 | journal = The Journal of pediatrics | volume = 143 | issue = 3 | pages = 399–401 | year = 2003 | pmid = 14517527 | doi = 10.1067/S0022-3476(03)00388-3 | author11 = Pediatric Rheumatlogy Study Group of Israel | author1 = Hashkes }}</ref>

除了风湿热外，[[川崎病|川崎病]]是少数几种可以让儿童服用阿司匹林的病症，<ref>{{cite journal|last1=Rowley|first1=AH|author2=Shulman, ST|title=Pathogenesis and management of Kawasaki disease|journal=Expert review of anti-infective therapy|date=February 2010|volume=8|issue=2|pages=197–203|pmid=20109049|doi=10.1586/eri.09.109|pmc=2845298}}</ref> 不过没有使用高剂量阿斯匹靈的证据证实它的效果。<ref>{{cite journal|last1=Baumer|first1=JH|author2=Love, SJ; Gupta, A; Haines, LC; Maconochie, I; Dua, JS|title=Salicylate for the treatment of Kawasaki disease in children|journal=Cochrane Database of Systematic Reviews|date=2006-10-18|issue=4|pages=CD004175|pmid=17054199|doi=10.1002/14651858.CD004175.pub2|editor1-last=Baumer|editor1-first=J Harry}}</ref>

低剂量（每日100毫克）的阿司匹林可以早期[[妊娠毒血症|妊娠毒血症]]的發生，但針對晚期患者效果並不顯著。且此效果必須在妊娠16周以前開始用藥，否則無顯著療效<ref>{{Cite journal|title=Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis|url=https://pubmed.ncbi.nlm.nih.gov/29138036/|last=Roberge|first=Stephanie|last2=Bujold|first2=Emmanuel|date=2018-03|journal=American Journal of Obstetrics and Gynecology|issue=3|doi=10.1016/j.ajog.2017.11.561|volume=218|pages=287–293.e1|issn=1097-6868|pmid=29138036|last3=Nicolaides|first3=Kypros H.|access-date=2021-03-26|archive-date=2020-06-29|archive-url=https://web.archive.org/web/20200629025001/https://pubmed.ncbi.nlm.nih.gov/29138036/}}</ref>。

==不良反应==
===禁忌===
<!--英文拼写：Contraindications-->
[[布洛芬|布洛芬]]或[[萘普生|萘普生]][[过敏|过敏]]的人群、<ref name="drugs.com"/><ref name="personalmd" />对[[水杨酸|水杨酸]]<ref name="pmid16247191">{{Cite journal | author = Raithel M | title = Significance of salicylate intolerance in diseases of the lower gastrointestinal tract | journal = J. Physiol. Pharmacol. | volume = 56 Suppl 5 | pages = 89–102 | year = 2005 | pmid = 16247191 | url = http://www.jpp.krakow.pl/journal/archive/09_05_s5/pdf/89_09_05_s5_article.pdf | format = PDF | author2 = Baenkler HW | author3 = Naegel A | last4 = Buchwald | first4 = F | last5 = Schultis | first5 = HW | last6 = Backhaus | first6 = B | last7 = Kimpel | first7 = S | last8 = Koch | first8 = H | last9 = Mach | first9 = K | first10 = EG | last10 = Hahn | first11 = PC | last11 = Konturek | access-date = 2015-06-07 | archive-url = https://web.archive.org/web/20110409093851/http://www.jpp.krakow.pl/journal/archive/09_05_s5/pdf/89_09_05_s5_article.pdf | archive-date = 2011-04-09 | dead-url = no }}</ref><ref name="pmid8566739">{{Cite journal | author = Senna GE, Andri G, Dama AR, Mezzelani P, Andri L | title = Tolerability of imidazole salycilate in aspirin-sensitive patients | journal = Allergy Proc | volume = 16 | issue = 5 | pages = 251–4 | year = 1995 | pmid = 8566739 | doi = 10.2500/108854195778702675 }}</ref>（或一般[[非甾体抗炎药|非甾体抗炎药]]）不耐受的人群禁用，患有[[哮喘|哮喘]]的人群或会因非甾体抗炎药导致[[支气管痉挛|支气管痉挛]]的人群慎用。
因为阿司匹林会对胃壁产生影响，生产厂商建议患有[[消化性溃疡|消化性溃疡]]、轻症[[糖尿病|糖尿病]]或[[胃炎|胃炎]]的人群在服用前先咨询医师。<ref name="drugs.com"/><ref name="mercksource">{{cite web |title=PDR Guide to Over the Counter (OTC) Drugs |url=http://www.mercksource.com/pp/us/cns/cns_hl_pdr.jspzQzpgzEzzSzppdocszSzuszSzcnszSzcontentzSzpdrotczSzotc_fullzSzdrugszSzfgotc036zPzhtm |accessdate=2008-04-28 |archiveurl=https://web.archive.org/web/20080410223441/http://www.mercksource.com/pp/us/cns/cns_hl_pdr.jspzQzpgzEzzSzppdocszSzuszSzcnszSzcontentzSzpdrotczSzotc_fullzSzdrugszSzfgotc036zPzhtm |archivedate=2008-04-10 |deadurl=no }}</ref> 即使没有上述情况，当阿司匹林与[[酒精|酒精]]或[[华法林|华法林]]同时服用时也有导致胃出血的风险。<ref name="drugs.com"/><ref name="personalmd" /> 患有[[血友病|血友病]]或其它出血性疾病的人群也不应服用该药及其它[[水杨酸|水杨酸]]类药物。<ref name="drugs.com"/><ref name="mercksource" /> 患有遗传性疾病[[葡萄糖-6-磷酸脱氢酶缺乏症|葡萄糖-6-磷酸脱氢酶缺乏症]]的人群服用阿司匹林会导致{{link-en|溶血性贫血|hemolytic anemia}}，这取决于用量的多少和病情的严重性。<ref>{{Cite book| title = Frequencies of hemoglobin variants: thalassemia, the glucose-6-phosphate dehydrogenase deficiency, G6PD variants, and ovalocytosis in human populations|url=http://books.google.com/?id=OjqNeJERhWwC&q=0195036344&dq=0195036344|publisher=Oxford University Press| isbn = 0-19-503634-4| author = Livingstone, Frank B. | year = 1985}}</ref> 不建议[[登革热|登革热]]患者服用该药，因为这会提高出血倾向。<ref>{{cite web |title=Dengue and Dengue Hemorrhagic Fever: Information for Health Care Practitioners |url=http://www.cdc.gov/NCIDOD/dvbid/dengue/dengue-hcp.htm |accessdate=2008-04-28 |archiveurl=https://web.archive.org/web/20080317070305/http://www.cdc.gov/Ncidod/dvbid/dengue/dengue-hcp.htm |archivedate=2008-03-17 |deadurl=yes }}</ref> 患有[[肾病|肾病]]、[[高尿酸血症|高尿酸血症]]或[[痛风|痛风]]的人群不宜服用，因为阿司匹林会抑制肾脏排出[[尿酸|尿酸]]的功能，从而加重病情。另外不应使用该药治疗儿童或青少年的[[发热|发热]]或[[流感|流感]]，因为这与患上[[瑞氏综合征|瑞氏综合征]]有关。<ref name="BMJ2002-Macdonald">{{cite journal | vauthors = Macdonald S | title = Aspirin use to be banned in under 16 year olds | journal = BMJ | volume = 325 | issue = 7371 | pages = 988c–988 | date = November 2002 | pmid = 12411346 | pmc = 1169585 | doi = 10.1136/bmj.325.7371.988/c }}</ref>

===胃肠道反应===
阿司匹林会增加消化道出血的风险。<ref name="H Toft">{{Cite journal|author=Sørensen HT |title=Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin |url=https://archive.org/details/sim_american-journal-of-gastroenterology_2000-09_95_9/page/2218 |journal=Am. J. Gastroenterol. |volume=95 |issue=9 |pages=2218–24 |year=2000 |pmid=11007221 |doi=10.1111/j.1572-0241.2000.02248.x |author2=Mellemkjaer L|author3=Blot WJ|last4=Nielsen|first4=Gunnar Lauge|last5=Steffensen|first5=Flemming Hald|last6=McLaughlin|first6=Joseph K.|last7=Olsen|first7=Jorgen H.}}</ref> 尽管有些{{link-en|肠溶片|enteric coating}}在广告中宣称“不伤胃”，但研究表明肠溶片并未降低出血风险。<ref name="H Toft" /> 若该药和其他非甾体抗炎药联用，出血风险还会增加。<ref name="H Toft" /> 阿司匹林和氯吡格雷或华法林联用也会增加上消化道出血的风险。<ref>{{Cite journal|author=Delaney JA, Opatrny L, Brophy JM & Suissa S |year=2007 |title=Drug–drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding |journal=CMAJ |volume=177 |issue=4 |pages=347–51 |pmid=17698822 |doi=10.1503/cmaj.070186 |pmc=1942107}}</ref>

阿司匹林对COX-1的抑制似乎启动了胃的防御机制，使COX-2活性增强，<ref>{{cite journal | last1 = Wallace | first1 = J. L. | title = Prostaglandins, NSAIDs, and Gastric Mucosal Protection: Why Doesn't the Stomach Digest Itself? | journal = Physiological Reviews | volume = 88 | issue = 4 | pages = 1547–1565 | year = 2008 | pmid = 18923189 | doi = 10.1152/physrev.00004.2008 | url = http://physrev.physiology.org/content/88/4/1547.full | author =  | access-date = 2015-08-14 | archive-url = https://web.archive.org/web/20141103055453/http://physrev.physiology.org/content/88/4/1547.full | archive-date = 2014-11-03 | dead-url = no }}</ref> 若同时服用COX-2抑制剂，则会增加对胃黏膜的侵蚀。<ref>{{cite journal | last1 = Fiorucci | first1 = S. | last2 = Santucci | first2 = L. | last3 = Wallace | first3 = J. L. | last4 = Sardina | first4 = M. | last5 = Romano | first5 = M. | last6 = Del Soldato | first6 = P. | last7 = Morelli | first7 = A. | title = Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa | journal = Proceedings of the National Academy of Sciences | volume = 100 | issue = 19 | pages = 10937–10941 | year = 2003 | pmid = 12960371 | pmc = 196906 | doi = 10.1073/pnas.1933204100 }}</ref> 因此，当阿司匹林与任何“天然”的会抑制COX-2的补充剂（如[[大蒜|大蒜]]提取物、姜黄素、[[越桔|越桔]]、松树皮、[[银杏|银杏]]、[[鱼油|鱼油]]、白藜芦醇、染料木黄酮、[[槲皮素|槲皮素]]、间苯二酚等）联用时，必须特别小心。

除了肠溶片外，制药公司还会利用“缓冲剂”来缓解消化道出血的问题。缓冲剂旨在防止阿司匹林集結在胃壁上，不过它的效用存在争议。几乎所有抗酸药里的缓冲剂都能使用，如Bufferin使用[[氧化镁|氧化镁]]，还有制剂使用[[碳酸钙|碳酸钙]]的。<ref>{{cite web |url=http://antoine.frostburg.edu/chem/senese/101/acidbase/faq/buffered-aspirin.shtml |title=General Chemistry Online: FAQ: Acids and bases: What is the buffer system in buffered aspirin? |publisher=Antoine.frostburg.edu |accessdate=2011-05-11 |archive-url=https://web.archive.org/web/20110414145143/http://antoine.frostburg.edu/chem/senese/101/acidbase/faq/buffered-aspirin.shtml |archive-date=2011-04-14 |dead-url=no }}</ref>

最近有对阿司匹林与[[维生素C|维生素C]]联用以保护胃黏膜的研究。服用相同剂量的维生素C和阿司匹林与单独服用阿司匹林相比，能减少对胃的伤害。<ref name="Dammann">{{cite journal | last1 = Dammann | first1 = H. G. | last2 = Saleki | first2 = M. | last3 = Torz | first3 = M. | last4 = Schulz | first4 = H. U. | last5 = Krupp | first5 = S. | last6 = Schürer | first6 = M. | last7 = Timm | first7 = J. | last8 = Gessner | first8 = U. | title = Effects of buffered and plain acetylsalicylic acid formulations with and without ascorbic acid on gastric mucosa in healthy subjects | journal = Alimentary pharmacology & therapeutics | volume = 19 | issue = 3 | pages = 367–374 | year = 2004 | pmid = 14984384 | doi = 10.1111/j.1365-2036.2004.01742.x }}</ref><ref name="Konturek">{{Cite journal | author = Konturek | title = Ascorbic acid attenuates aspirin-induced gastric damage: role of inducible nitric oxide synthase | journal = J Physiol Pharmacol. | year = 2006 | issue = 5 | pages = 125–36 | pmid = 17218764 | last2 = Kania | first2 = J | last3 = Hahn | first3 = EG | last4 = Konturek | first4 = JW | volume = 57 Suppl 5 }}</ref>

===对中枢神经系统的影响===
大鼠实验表明，阿司匹林的代谢物[[水杨酸|水杨酸]]在大剂量时能引起暂时性[[耳鸣|耳鸣]]，这是由于[[花生四烯酸|花生四烯酸]]的作用和[[谷丙轉氨酶|谷丙轉氨酶]]级联反应。<ref name="Gutton">{{Cite journal |author=Guitton MJ, Caston J, Ruel J, Johnson RM, Pujol R, Puel JL |title=Salicylate induces tinnitus through activation of cochlear NMDA receptors |journal=J. Neurosci. |volume=23 |issue=9 |pages=3944–52 |year=2003 |pmid=12736364 |url=http://www.jneurosci.org/cgi/content/full/23/9/3944 |access-date=2015-08-14 |archive-url=https://web.archive.org/web/20071222105912/http://www.jneurosci.org/cgi/content/full/23/9/3944 |archive-date=2007-12-22 |dead-url=yes }}</ref>

===瑞氏综合征===
{{main|瑞氏综合征}}

瑞氏综合征是一种罕见的严重疾病，特征是急性[[脑病|脑病]]和[[脂肪肝|脂肪肝]]，发生在少年儿童服用阿司匹林治疗发热或其他感染时。从1981年到1997年，[[美国疾病控制与预防中心|美国疾病控制与预防中心]]接到1207宗未满18岁的瑞氏综合征病患报告。其中93%在综合征出现三周之前就已患病，主要是[[呼吸道感染|呼吸道感染]]、[[水痘|水痘]]和[[腹泻|腹泻]]。81.9%的受检儿童都检出了水杨酸。<ref name=Belay>{{Cite journal|author=Belay ED, Bresee JS, Holman RC, Khan AS, Shahriari A, Schonberger LB |title=Reye's syndrome in the United States from 1981 through 1997 |journal=N. Engl. J. Med. |volume=340 |issue=18 |pages=1377–82 |year=1999 |pmid=10228187 |doi= 10.1056/NEJM199905063401801}}</ref> 出现阿司匹林引起瑞氏综合征的报告后，美国就采取了预防性的安全措施（如{{link-en|美国卫生局局长|Surgeon General of the United States|卫生局局长}}发出警告，更改含阿司匹林药品的标识），美国儿童的阿司匹林用量明显下降，瑞氏综合征的病例报告也明显减少。同样，英国发出儿童不宜服用阿司匹林的警告后，药物用量和病例报告也有减少。<ref name=Belay />[[美国食品药品监督管理局|美国食品药品监督管理局]]现在建议12岁以下儿童发热都不能服用阿司匹林或含有阿司匹林的药物。<ref name="BMJ2002-Macdonald"/> 英国{{link-en|药品和医疗产品监管署|Medicines and Healthcare Products Regulatory Agency}}也建议16岁以下儿童不应服用阿司匹林，除非另有医嘱。<ref>{{cite web |url=http://www.nhs.uk/conditions/Reyes-syndrome/Pages/Introduction.aspx |title=Reye's syndrome |publisher=[[NHS|NHS]] |accessdate=2015-08-14 |archive-url=https://web.archive.org/web/20160809194915/http://www.nhs.uk/Conditions/Reyes-syndrome/Pages/Introduction.aspx |archive-date=2016-08-09 |dead-url=no }}</ref>

===其他不良反应===
小部分人服用阿司匹林后会产生类似于过敏的反应，如[[荨麻疹|荨麻疹]]、水肿和头痛。这种反应是由于{{link-en|水杨酸不耐受|salicylate intolerance}}，并不是真正的[[过敏|过敏]]，而是连一点点水杨酸都无法代谢所导致的[[药物过量|药物过量]]。

有些人服用阿司匹林会产生[[血管性水肿|皮肤组织水肿]]，有研究发现有些病患服药1到6小时后就会发生。不过，阿司匹林单独服用并不会导致水肿，和非甾体抗炎药联用时才会发生。<ref>{{Cite journal|author=Berges-Gimeno MP & Stevenson DD |year=2004 |title=Nonsteroidal anti-inflammatory drug-induced reactions and desensitization |journal=J Asthma |volume=41 |issue=4 |pages=375–84 |pmid=15281324 |doi=10.1081/JAS-120037650}}</ref>

阿司匹林会增加脑部微出血的风险，[[磁共振成像|磁共振成像]]（MRI）可见5至10毫米的斑块，或者是更小的低信号斑块。<ref>{{cite journal | author = Vernooij MW, Haag MD, der Lugt A, Hofman A, Krestin GP, Stricker BH, Breteler MM | year = 2009 | title = Use of antithrombotic drugs and the presence of cerebral microbleeds: the Rotterdam Scan Study| journal = Arch Neurol | volume = 66 | issue = 6| pages = 714–20 | pmid = 19364926 | doi=10.1001/archneurol.2009.42}}</ref><ref>{{cite journal | author = Gorelick PB | year = 2009 | title = Cerebral microbleeds: evidence of heightened risk associated with aspirin use | journal = Arch Neurol | volume = 66 | issue = 6| pages = 691–3 | pmid = 19506128 | doi=10.1001/archneurol.2009.85}}</ref>

一项研究估计每天平均服用270毫克的阿司匹林后，[[脑出血|脑出血]]（ICH）的概率绝对值增加了万分之12，<ref name=He1998/> 与此相比，[[心肌梗死|心肌梗死]]的概率绝对值下降了万分之137，缺血性中风的概率绝对值则下降了万分之39。<ref name=He1998>{{cite journal | last1 = He | first1 = J. | last2 = Whelton | first2 = P. K. | last3 = Vu | first3 = B. | last4 = Klag | first4 = M. J. | title = Aspirin and risk of hemorrhagic stroke: A meta-analysis of randomized controlled trials | journal = JAMA: the Journal of the American Medical Association | volume = 280 | issue = 22 | pages = 1930–1935 | year = 1998 | pmid = 9851479 | doi = 10.1001/jama.280.22.1930 }}</ref> 如果已经发生脑出血，阿司匹林会提高死亡率，每天大约250毫克的剂量导致发病后三个月内死亡的概率是原来的2.5倍（95%[[置信区间|置信区间]]是1.3倍到4.6倍）<ref name="Saloheimo2006">{{cite journal|title=Regular Aspirin-Use Preceding the Onset of Primary Intracerebral Hemorrhage is an Independent Predictor for Death|first1=P.|last2=Ahonen|first2=M.|journal=Stroke|issue=1|doi=10.1161/01.STR.0000196991.03618.31|year=2005|volume=37|pages=129–133|pmc=|pmid=16322483|last3=Juvela|first3=S.|last4=Pyhtinen|first4=J.|last5=Savolainen|first5=E. R.|last6=Hillbom|first6=M.|last1=Saloheimo}} <!--cite doi not quite connecting to right place{{cite journal|title=Regular Aspirin-Use Preceding the Onset of Primary Intracerebral Hemorrhage is an Independent Predictor for Death|journal=Stroke|date=2006-01-01|url=http://stroke.ahajournals.org/content/37/1/129|language=en|volume=37|issue=1|doi=10.1161/01.str.0000196991.03618.31|pages=129–133|issn=0039-2499|accessdate=2018-04-02|author=Pertti Saloheimo, Mikko Ahonen, Seppo Juvela, Juhani Pyhtinen, Eeva-Riitta Savolainen, Matti Hillbom|archive-url=https://web.archive.org/web/20180604175607/http://stroke.ahajournals.org/content/37/1/129|archive-date=2018-06-04|dead-url=no}}--></ref>。

阿司匹林和其他非甾体抗炎药会抑制[[前列腺素|前列腺素]]合成，引起低肾素性[[低醛固酮症|低醛固酮症]]，可能引发[[高血钾症|高血钾症]]。不过，当肾功能和血容量都正常时，这些药物并不会导致高血钾症。<ref>{{cite book|title=Medical knowledge self-assessment program for students 4|publisher=American College of Physicians|author=Clerkship Directors in Internal Medicine|volume=Nephrology 227, Item 29}}</ref>

阿司匹林在术后十天内都能引起长时间出血。一项研究选择了6499名手术病人进行观察，发现其中有30人需要再次进行手术以控制出血。这30人中有20人是弥漫性出血，另外10人只有一个部位出血。弥漫性出血是由术前单独使用阿司匹林或和其他非甾体抗炎药联用引起的，而离散的出血则不是。<ref>{{Cite journal|author=Scher, K.S. |year=1996 |title=Unplanned reoperation for bleeding |journal=Am Surg |volume=62 |issue=1 |pages=52–55 |pmid=8540646}}</ref>

2015年7月9日，美国食品药品监督管理局提升了对非甾体抗炎药增加心脏病和中风风险的警告。阿司匹林虽然也是非甾体抗炎药，但并不在警告的范围内。<ref name="FDA-20150709">{{cite web |author=Staff |title=FDA Strengthens Warning of Heart Attack and Stroke Risk for Non-Steroidal Anti-Inflammatory Drugs |url=http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm453610.htm |date=2015-07-09 |work=[[FDA|FDA]] |accessdate=2015-07-09 |archive-url=https://web.archive.org/web/20150711004922/http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm453610.htm |archive-date=2015-07-11 |dead-url=no }}</ref>

{{Bleeding worksheet}}

===过量服用===
阿司匹林过量分为急性和慢性。急性过量是指一次性服用大剂量的药物，而慢性过量则是指一段时间内服用超过正常剂量的药物。急性过量的[[死亡率|死亡率]]是2%。慢性过量的死亡率更高達25%，<ref>{{cite web|author=Kreplick, LW.|year=2001|title=Salicylate Toxicity in Emergency Medicine|publisher={{le|Medscape|Medscape}}|url=http://misc.medscape.com/pi/android/medscapeapp/html/A818242-business.html|access-date=2015-08-15|archive-url=https://web.archive.org/web/20120831184805/http://misc.medscape.com/pi/android/medscapeapp/html/A818242-business.html|archive-date=2012-08-31|dead-url=no}}</ref>慢性過量的死亡率之所以高於急性過量除了因為沒有明確的過量攝入史，再加上其典型症狀和體徵往往輕微或不存在，儘管發現臨床症狀重疊，在慢性過量的病例中初步診斷仍可能歸因於其他疾病。<ref>{{Cite journal |last=Palmer |first=Biff F. |last2=Clegg |first2=Deborah J. |date=2020-06-24 |title=Salicylate Toxicity |url=https://www.nejm.org/doi/10.1056/NEJMra2010852 |journal=New England Journal of Medicine |language=en |doi=10.1056/NEJMra2010852 |access-date=2022-05-11 |archive-date=2022-05-11 |archive-url=https://web.archive.org/web/20220511134757/https://www.nejm.org/doi/10.1056/NEJMra2010852 }}</ref>且对儿童影响尤为严重。<ref name="Pediatrics1982-gaudreault">{{Cite journal|author=Gaudreault P, Temple AR, Lovejoy FH Jr |title=The relative severity of acute versus chronic salicylate poisoning in children: a clinical comparison |url=https://archive.org/details/sim_pediatrics_1982-10_70_4/page/566 |journal=Pediatrics |year=1982 |pages=566–9 |volume=70 |issue=4 |pmid= 7122154}} (primary source)</ref> 中毒的治疗方法有使用[[活性炭|活性炭]]、[[静脉注射|静脉注射]][[葡萄糖|葡萄糖]]和[[生理盐水|生理盐水]]，使用[[碳酸氢钠|碳酸氢钠]]，还有[[透析|透析]]。<ref>{{Cite book |title=Rosen's emergency medicine: concepts and clinical practice |last=Marx |first=John |year=2006 |publisher=Mosby/Elsevier |isbn=978-0-323-02845-5 |page=2242}}</ref> 通常用自动分光光度法测量血浆中阿司匹林的活性代谢产物，即水杨酸来诊断中毒。一般来说，正常服药治疗后血浆中水杨酸含量为30-100毫克每升，高剂量服用的患者血浆中的含量为50-300毫克每升，急性中毒患者血浆中的含量为700-1400毫克每升。服用[[次水杨酸铋|次水杨酸铋]]、[[水杨酸甲酯|水杨酸甲酯]]和[[水杨酸钠|水杨酸钠]]后也会产生水杨酸。<ref>{{cite journal |author=Morra P, Bartle WR, Walker SE, Lee SN, Bowles SK, Reeves RA |title=Serum concentrations of salicylic acid following topically applied salicylate derivatives |url=https://archive.org/details/sim_annals-of-pharmacotherapy_1996-09_30_9/page/935 |journal=Ann. Pharmacother |volume=30 |pages=935–40 |year=1996 |pmid=8876850 |issue=9}}</ref><ref>{{cite book |author=R. Baselt |title=Disposition of Toxic Drugs and Chemicals in Man |edition=9th |publisher=Biomedical Publications |location=Seal Beach, California |year=2011 |pages=20–23}}</ref>

===互相作用===
阿司匹林和其他藥物會发生[[藥物互相作用|互相作用]]，如[[乙酰唑胺|乙酰唑胺]]和[[氯化铵|氯化铵]]会增加水杨酸的毒性，酒精则会增加该药导致胃肠道出血的风险<ref name='drugs.com'>{{cite web |url=http://www.drugs.com/aspirin.html |title=Aspirin information from Drugs.com |accessdate=2008-05-08 |publisher=Drugs.com |archiveurl=https://web.archive.org/web/20080509163105/http://www.drugs.com/aspirin.html |archivedate=2008-05-09 |deadurl=no }}</ref><ref name='personalmd'>{{cite web |url=http://www.personalmd.com/drgdb/3.htm |title=Oral Aspirin information |accessdate=2008-05-08 |publisher=First DataBank |archiveurl=https://web.archive.org/web/20080609015511/http://www.personalmd.com/drgdb/3.htm |archivedate=2008-06-09 |deadurl=yes }}</ref> 血液中阿司匹林还会影响部分药物与蛋白质结合，包括[[抗糖尿病药|抗糖尿病药]]（{{link-en|甲苯磺丁脲|tolbutamide}}和{{link-en|氯磺丙脲|chlorpropamide}}）、[[华法林|华法林]]、[[氨甲蝶呤|氨甲蝶呤]]、[[苯妥英|苯妥英]]、{{link-en|丙磺舒|Probenecid}}、[[丙戊酸|丙戊酸]]（会影响该药代谢中的重要一环[[β-氧化|β-氧化]]）和其他非甾体抗炎药。另外[[皮质类固醇|皮质类固醇]]能降低阿司匹林的浓度，[[布洛芬|布洛芬]]会抵消阿司匹林的抗血栓作用，影响其保护心血管和预防中风的功能。<ref name='FDA2006'>{{cite web | url = http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm125222.htm | title = Information for Healthcare Professionals: Concomitant Use of Ibuprofen and Aspirin | accessdate = 2010-11-22 | date = September 2006 | work = FDA | publisher = [[美國衛生與人群服務部|United States Department of Health and Human Services]] | archiveurl = https://web.archive.org/web/20101113035657/http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm125222.htm | archivedate = 2010-11-13 | deadurl = no }}</ref> 阿司匹林会降低[[安体舒通|安体舒通]]的药理活性，经由肾小管分泌时还会与[[青霉素G|青霉素G]]竞争。<ref name="interactions">{{cite book|author=Katzung|year=1998|title=Basic and Clinical Pharmacology|publisher=McGraw-Hill|page=584}}</ref> 阿司匹林也会抑制[[维生素C|维生素C]]的吸收。<ref>{{Cite journal |author=Loh HS, Watters K & Wilson CW |date=1973-11-01 |title=The Effects of Aspirin on the Metabolic Availability of Ascorbic Acid in Human Beings |journal=J Clin Pharmacol |volume=13 |issue=11 |pages=480–6 |pmid=4490672 |url=http://jcp.sagepub.com/cgi/content/abstract/13/11/480 |doi=10.1002/j.1552-4604.1973.tb00203.x |deadurl=yes |archiveurl=https://web.archive.org/web/20070316233244/http://jcp.sagepub.com/cgi/content/abstract/13/11/480 |archivedate=2007-03-16 |access-date=2015-08-15 }}</ref><ref>{{Cite journal|author=Basu TK |year=1982 |title=Vitamin C-aspirin interactions |journal=Int J Vitam Nutr Res Suppl |volume=23 |pages=83–90 |pmid=6811490}}</ref><ref>{{Cite journal|author=Ioannides C, Stone AN, Breacker PJ & Basu TK |year=1982 |title=Impairment of absorption of ascorbic acid following ingestion of aspirin in guinea pigs |journal=[[Biochem_Pharmacol|Biochem Pharmacol]] |volume=31 |issue=24 |pages=4035–8 |pmid=6818974 |doi=10.1016/0006-2952(82)90652-9}}</ref>

===耐药性===
在有些人身上，阿司匹林的抗血栓作用不如别的人明显，这种现象称为阿司匹林耐药性或是对阿司匹林不敏感。研究表明女性比男性更易产生耐药性，<ref>{{Cite journal|author=Dorsch MP, Lee JS, Lynch DR, Dunn SP, Rodgers JE, Schwartz T, Colby E, Montague D, Smyth SS |title=Aspirin Resistance in Patients with Stable Coronary Artery Disease with and without a History of Myocardial Infarction |journal=Annals of Pharmacotherapy |volume= 41|issue=May |year=2007 |pmid=17456544|doi=10.1345/aph.1H621|pages=737–41}}</ref> 另一项研究总共调查了2930人，发现有28%的人有耐药性。<ref name="pmid18202034">{{Cite journal|author=Krasopoulos G, Brister SJ, Beattie WS, Buchanan MR |title=Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis |journal=BMJ |volume=336 |issue=7637 |pages=195–8 |year=2008 |pmid=18202034 |pmc=2213873|doi=10.1136/bmj.39430.529549.BE}}</ref> 不过还有一项针对100名意大利人的研究表明，虽然看上去有31%的人耐药，不过只有5%的人是真正耐药的，其他人只是没按要求服药而已。<ref name="pmid18680540">{{Cite journal|author=Pignatelli P, Di Santo S, Barillà F, Gaudio C, Violi F|title=Multiple anti-atherosclerotic treatments impair aspirin compliance: effects on aspirin resistance |journal=J. Thromb. Haemost.|volume=6 |issue=10 |pages=1832–4 |year=2008 |pmid=18680540 |doi=10.1111/j.1538-7836.2008.03122.x}}</ref> 另一项研究在400名健康志愿者中没有发现真正对阿司匹林有抗药性的人，但有服用肠溶阿司匹林的人出现“伪耐药性，体现为药物吸收的延迟和减少”。<ref>{{cite journal|doi=10.1161/CIRCULATIONAHA.112.117283|journal=Circulation|title=Drug Resistance and Pseudoresistance: An Unintended Consequence of Enteric Coating Aspirin|laysummary=http://www.nytimes.com/2012/12/05/business/coating-on-buffered-aspirin-may-hide-its-heart-protective-effects.html?|publication-date=4 December 2012|laysource=The New York Times|laydate=4 December 2012|author=Tilo Grosser, Susanne Fries, John A. Lawson, Shiv C. Kapoor, Gregory R. Grant and Garret A. FitzGerald|pmid=23212718|year=2013|volume=127|issue=3|pages=377–85|pmc=3552520|access-date=2015-08-14|archive-date=2015-09-15|archive-url=https://web.archive.org/web/20150915045832/http://www.nytimes.com/2012/12/05/business/coating-on-buffered-aspirin-may-hide-its-heart-protective-effects.html|dead-url=no}}</ref>
<!--Please note that I do not have access to the full text of this source. The abstract and lay summary state that pseudoresistance occurs with enteric-coated aspirin only. Please check the full text of the article to see whether the resistance or pseudoresistance is really caused by the enteric coating or not.-->
<!-- "Pseudoresistance, reflecting delayed and reduced drug absorption, complicates enteric coated but not immediate release aspirin administration."-->

==性质==
阿司匹林是一种白色晶体，[[熔点|熔点]]{{convert|136|C|F}}，在{{convert|140|C|F}}时分解<ref name="Myers2007">{{cite book|author=Richard Leroy Myers|title=The 100 Most Important Chemical Compounds: A Reference Guide|url=https://books.google.com/books?id=MwpQWcIKMzAC&pg=PA10|accessdate=2012-11-18|date=2007-08-30|publisher=ABC-CLIO|isbn=978-0-313-33758-1|page=10|archive-date=2013-06-10|archive-url=https://web.archive.org/web/20130610170345/http://books.google.com/books?id=MwpQWcIKMzAC&pg=PA10|dead-url=no}}</ref>。

阿司匹林是水杨酸的[[乙酰|乙酰]]衍生物，呈弱酸性，在{{convert|25|C|F}}下[[酸度系数|酸度系数]]为3.5。<ref name="asaaciddissconst">{{cite web|title = Acetylsalicylic acid|publisher = Jinno Laboratory, School of Materials Science, Toyohashi University of Technology|date = 1996-03-04|url = http://chrom.tutms.tut.ac.jp/JINNO/DRUGDATA/07acetylsalicylic_acid.html|archiveurl = https://web.archive.org/web/20120120224558/http://chrom.tutms.tut.ac.jp/JINNO/DRUGDATA/07acetylsalicylic_acid.html|archivedate = 2012-01-20|accessdate = 2014-04-12|dead-url = yes}}</ref> 阿司匹林可以在[[醋酸铵|醋酸铵]]或[[碱金属|碱金属]]的[[醋酸盐|醋酸盐]]、[[碳酸盐|碳酸盐]]、[[柠檬酸盐|柠檬酸盐]]和[[氢氧化物|氢氧化物]]溶液中迅速分解。阿司匹林在干燥空气中性质稳定，但在潮湿的环境中会逐渐[[水解|水解]]成[[乙酸|乙酸]]和[[水杨酸|水杨酸]]。在碱性溶液中，阿司匹林迅速水解，生成只含有水杨酸盐与乙酸盐的澄清溶液。<ref>{{cite encyclopedia|editor=EF Reynolds|encyclopedia=Martindale: The Extra Pharmacopoeia|edition=28th|year=1982|pages=234–82|title=Aspirin and similar analgesic and anti-inflammatory agents}}</ref>

如同[[面粉厂|面粉厂]]一样，生产阿司匹林的工厂也需要留意空气中阿司匹林的含量，因为过量的粉末会导致[[粉尘爆炸|粉尘爆炸]]。在美国，[[美国国家职业安全卫生研究所|美国国家职业安全卫生研究所]]（NIOSH）将{{link-en|建议暴露限值|recommended exposure limit}}定为5毫克每立方米（时间加权平均）。<ref>{{Cite web|url = http://www.cdc.gov/niosh/npg/npgd0010.html|title = Acetylsalicylic acid|date = 2015-02-13|accessdate = |website = Pocket Guide to Chemical Hazards|publisher = NIOSH|last = |first = |archive-url = https://web.archive.org/web/20150530222806/http://www.cdc.gov/niosh/npg/npgd0010.html|archive-date = 2015-05-30|dead-url = no}}</ref>1989年，美国{{link-en|职业安全与健康管理局|Occupational Safety and Health Administration}}（OSHA）将{{link-en|允许最大暴露限值|permissible exposure limit}}定为5毫克每立方米，但这项规定在1993年OSHA和[[美国劳工联合会-产业工会联合会|美国劳工联合会-产业工会联合会]]（AFL–CIO）的诉讼中被废除。 <ref>{{Cite web|url = http://www.cdc.gov/niosh/npg/nengapdxg.html|title = Appendix G: 1989 Air Contaminants Update Project - Exposure Limits NOT in Effect|date = 2015-02-13|accessdate = |website = NIOSH Pocket Guide to Chemical Hazards|publisher = NIOSH|last = |first = |archive-url = https://web.archive.org/web/20150630023354/http://www.cdc.gov/niosh/npg/nengapdxg.html|archive-date = 2015-06-30|dead-url = no}}</ref>

===多晶型性===
[[多晶型性|多晶型性]]是同一种物质形成多种[[晶体结构|晶体结构]]的能力，它对药物成分的开发至关重要。很多药物只有一种晶体结构经过监管部门批准。有很长一段时间，人们只知道阿司匹林的一种晶体结构，从1960年起开始怀疑它还有一种晶体结构，2005年才发现了这种神秘的结构。<ref name=Vishweshwar>{{cite journal | last1 = Vishweshwar | first1 = P. | last2 = McMahon | first2 = J. A. | last3 = Oliveira | first3 = M. | last4 = Peterson | first4 = M. L. | last5 = Zaworotko | first5 = M. J. | title = The Predictably Elusive Form II of Aspirin | journal = Journal of the American Chemical Society | volume = 127 | issue = 48 | pages = 16802–16803 | year = 2005 | pmid = 16316223 | pmc =  | doi = 10.1021/ja056455b }}</ref> 邦德等人测定了这种结构的细节。<ref>{{Cite journal|author= Bond, Andrew D.; Boese, Roland; and Desiraju, Gautam R. |title = On the Polymorphism of Aspirin: Crystalline Aspirin as Intergrowths of Two "Polymorphic" Domains|journal = [[Angewandte_Chemie_International_Edition|Angewandte Chemie International Edition]]|year = 2007|volume = 46|issue = 4|pages = 618–622|doi = 10.1002/anie.200603373|pmid= 17139692}}</ref> 这种新的晶体结构是在热[[乙腈|乙腈]]中使阿司匹林和{{link-en|左乙拉西坦|Levetiracetam}}共同结晶时发现的。<ref name=Vishweshwar/> <!--{cn|第二种结构只有在100 [[开尔文|K]]时才稳定，在室温下会转化成第一种结构。在第一种结构中，两个水杨酸分子形成中心对称的[[二聚体|二聚体]]，其中呈酸性的[[甲基|甲基]]提供质子与[[羰基|羰基]]形成[[氢键|氢键]]，而在新合成的第二种结构中，每个水杨酸分子不是和一个分子，而是和相邻的两个分子形成这种氢键。两种结构中[[羧基|羧基]]所形成的氢键相同，都是形成二聚体。-->

==制法==
制取阿司匹林的反应通常归为[[酯化反应|酯化反应]]。[[水杨酸|水杨酸]]和[[乙酸酐|乙酸酐]]（一种乙酸的衍生物）发生反应，水杨酸中的[[羟基|羟基]]替换为[[酯基|酯基]]（R-OH → R-OCOCH<sub>3</sub>），生成阿司匹林和副产物[[乙酸|乙酸]]。通常用少量[[硫酸|硫酸]]作催化剂（有时用[[磷酸|磷酸]]）。<ref>{{Cite book|title=Experimental Organic Chemistry |url=https://archive.org/details/experimentalorga0000pall |last=Palleros |first=Daniel R. |year=2000 |publisher=John Wiley & Sons|location=New York|isbn=0-471-28250-2 |page=[https://archive.org/details/experimentalorga0000pall/page/494 494]}}</ref>

:[[File:Aspirin_synthesis.png|490px]]

;反应机理
:[[File:Acetylation_of_salicylic_acid,_mechanism.png|Acetylation of salicylic acid, mechanism]]

含高浓度阿司匹林的制剂常有[[醋|醋]]味，<ref>{{cite web |url=http://www.newton.dep.anl.gov/askasci/chem00/chem00314.htm |title=Aspirin Aging |accessdate=2008-05-08 |last=Barrans |first=Richard |publisher=Newton BBS |archiveurl=https://web.archive.org/web/20080518213137/http://www.newton.dep.anl.gov/askasci/chem00/chem00314.htm |archivedate=2008-05-18 |deadurl=no }}</ref>这是因为阿司匹林会在潮湿的环境下发生[[水解反应|水解]]，分子分解成[[水杨酸|水杨酸]]和[[乙酸|乙酸]]。<ref>{{Cite journal | last1 = Carstensen | first1 = J.T. | author2 = F Attarchi and XP Hou | title = Decomposition of aspirin in the solid state in the presence of limited amounts of moisture | journal = Journal of Pharmaceutical Sciences | volume = 77 | issue = 4 | pages = 318–21 | year = 1985 | pmid = 4032246 | doi = 10.1002/jps.2600770407 }}</ref>

==作用机理==
1971年，{{link-en|英国皇家外科学院|Royal College of Surgeons of England}}的[[药理学家|药理学家]][[约翰·范恩|约翰·范恩]]证实了阿司匹林会抑制[[前列腺素|前列腺素]]和[[血栓素|血栓素]]的生成<ref>{{Cite journal|title = Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs|author = Vane, John Robert | journal = Nature – New Biology| year = 1971| volume = 231| issue = 25| pages = 232–5| pmid= 5284360|doi = 10.1038/newbio231232a0}}</ref><ref>{{Cite journal |author=Vane JR, Botting RM |year=2003 |title=The mechanism of action of aspirin |journal=Thromb Res |volume=110 |issue=5–6 |pages=255–8 |pmid=14592543 |doi=10.1016/S0049-3848(03)00379-7 |url=http://www.eao.chups.jussieu.fr/polys/certifopt/saule_coxib/theme/1vane2003.pdf |format=PDF |last2=Botting |access-date=2015-08-16 |archive-url=https://web.archive.org/web/20080228023239/http://www.eao.chups.jussieu.fr/polys/certifopt/saule_coxib/theme/1vane2003.pdf |archive-date=2008-02-28 |dead-url=yes }}</ref> 他因这项发现和[[苏恩·伯格斯特龙|苏恩·伯格斯特龙]]、[[本格特·萨米尔松|本格特·萨米尔松]]共同获得1982年[[诺贝尔生理学或医学奖|诺贝尔生理学或医学奖]]。<ref>{{cite web |url=http://www.nobelprize.org/nobel_prizes/medicine/laureates/1982/ |title=The Nobel Prize in Physiology or Medicine 1982 |publisher=Nobelprize.or |access-date=2015-08-16 |archive-url=https://www.webcitation.org/6BQYli5Sf?url=http://www.nobelprize.org/nobel_prizes/medicine/laureates/1982/ |archive-date=2012-10-15 |dead-url=no }}</ref> 1984年获授[[下级勋位爵士|下级勋位爵士]]。<ref name="Moncada pp. 401–411">{{cite journal | last=Moncada | first=S. | title=Sir John Robert Vane. 29 March 1927 -- 19 November 2004: Elected FRS 1974 | journal=Biographical Memoirs of Fellows of the Royal Society | publisher=The Royal Society | volume=52 | issue=0 | date=2006-12-01 | issn=0080-4606 | doi=10.1098/rsbm.2006.0027 | pages=401–411}}</ref>

===对前列腺素和血栓素的抑制===
阿司匹林能抑制前列腺素和血栓素是因为该药能不可逆地使合成前列腺素和血栓素所需的[[环氧合酶|环氧合酶]]（COX，学名叫前列腺素氧化环化酶，PTGS）失活。阿司匹林能使PTGS[[活性位点|活性位点]]中的一个[[丝氨酸|丝氨酸]]残基[[乙酰化|乙酰化]]，这是它和其他非甾体抗炎药（如[[双氯芬酸钠|双氯芬酸钠]]和[[布洛芬|布洛芬]]）的不同之处，因为其他的药抑制作用都是可逆的<ref>{{Cite journal|title=Diclofenac and NS-398, a selective cyclooxygenase-2 inhibitor, decrease agonist-induced contractions of the pig isolated ureter|url=http://www.ncbi.nlm.nih.gov/pubmed/11221916|last=Mastrangelo|first=D.|last2=Wisard|first2=M.|date=2000-12-01|journal=Urological Research|issue=6|volume=28|pages=376–382|issn=0300-5623|pmid=11221916|last3=Rohner|first3=S.|last4=Leisinger|first4=H.|last5=Iselin|first5=C. E.|author=|access-date=2016-02-25|archive-url=https://web.archive.org/web/20160919063855/http://www.ncbi.nlm.nih.gov/pubmed/11221916|archive-date=2016-09-19|dead-url=no}}</ref><ref>{{Cite journal|title=Differential Sensitivity and Mechanism of Inhibition of COX-2 Oxygenation of Arachidonic Acid and 2-Arachidonoylglycerol by Ibuprofen and Mefenamic Acid|url=http://pubs.acs.org/doi/abs/10.1021/bi900999z|last=Prusakiewicz|first=Jeffery J.|last2=Duggan|first2=Kelsey C.|date=2009-07-20|journal=Biochemistry|issue=31|doi=10.1021/bi900999z|volume=48|pages=7353–7355|language=EN|pmc=2720641|pmid=19603831|last3=Rouzer|first3=Carol A.|last4=Marnett|first4=Lawrence J.|access-date=2016-02-25|archive-date=2020-09-17|archive-url=https://web.archive.org/web/20200917150522/https://pubs.acs.org/doi/abs/10.1021/bi900999z}}</ref>。

阿司匹林低剂量服用时能阻止血小板中[[血栓素A2|血栓素A2]]的合成，这会在受影响的血小板的生命周期（约8–9天）内抑制血小板聚集。阿司匹林的这种抗血栓作用可用于降低心脏病发生率。<ref>{{cite web |url=http://www.americanheart.org/presenter.jhtml?identifier=4456 |title=Aspirin in Heart Attack and Stroke Prevention |accessdate=2008-05-08 |publisher=American Heart Association |archiveurl=https://web.archive.org/web/20080331031146/http://www.americanheart.org/presenter.jhtml?identifier=4456 |archivedate=2008-03-31 |dead-url=no }}</ref> 每天服用40 mg的阿司匹林能显著抑制血栓素A2的最大急性合成量，但不影响前列腺素I2的合成，不过服用剂量更高时就会抑制前列腺素I2的合成。<ref>{{Cite journal |last1=Tohgi |first1=H |author2=S Konno, K Tamura, B Kimura and K Kawano|year = 1992|title = Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin|url=https://archive.org/details/sim_stroke_1992-10_23_10/page/1400 |journal = Stroke| volume = 23|pages = 1400–1403 |pmid=1412574|issue = 10| doi=10.1161/01.STR.23.10.1400}}</ref>

前列腺素是身体局部产生的一种[[激素|激素]]，它有多种作用，包括在[[下丘脑|下丘脑]]中调节体温<ref name="VealeCooper1977">{{cite journal|last1=Veale|first1=W. L.|last2=Cooper|first2=K. E.|last3=Pittman|first3=Q. J.|title=Role of Prostaglandins in Fever and Temperature Regulation|year=1977|pages=145–167|doi=10.1007/978-1-4615-8055-3_6|PMC=3081099}}</ref>
，将痛觉传递到大脑，还会引起炎症<ref name="RicciottiFitzGerald2011">{{cite journal|last1=Ricciotti|first1=E.|last2=FitzGerald|first2=G. A.|title=Prostaglandins and Inflammation|url=https://archive.org/details/sim_arteriosclerosis-thrombosis-and-vascular-biology_2011-05_31_5/page/986|journal=Arteriosclerosis, Thrombosis, and Vascular Biology|volume=31|issue=5|year=2011|pages=986–1000|issn=1079-5642|doi=10.1161/ATVBAHA.110.207449}}</ref><ref>{{Cite book|title = Rubin's Pathology 6th edition|last = Rumin|first = Raphel|publisher = Wolters Kluwer|year = 2011|isbn = 978-1-4511-0912-2|location = USA|pages = 59}}</ref>。血栓素会使血小板聚集形成[[血栓|血栓]]，而心肌梗死主要是由血栓导致的，因此低剂量服用阿司匹林能有效防止心肌梗死<ref name="BNF" />。

===对COX-1和COX-2的抑制===
阿司匹林可以抑制环氧化酶-1（COX-1）和环氧化酶-2（COX-2）。它能不可逆地抑制COX-1并且改变COX-2的酶活性。COX-2通常产生的大多是会促进发炎的{{link-en|前列腺素类激素|Prostanoid}}，但受阿司匹林作用后则产生能抗炎的{{link-en|脂氧素|lipoxin}}。新一代非甾体抗炎药——昔布类{{link-en|COX-2抑制剂|COX-2 inhibitor}}——可以单独抑制COX-2，以减少对胃肠道的副作用。<ref>{{cite journal|
volume=2|issue=3|title=Pharmacokinetic Solubility And Dissolution Profile of Non-Steroidal Anti-Inflammatory Drugs|author=Achhrish goel, Ruchi gupta Anubhav goswami Madhu soodan sharma Yogesh sharma|year=2011}}</ref><ref name="COX2002" />

然而许多新一代的COX-2抑制剂如[[罗非昔布|罗非昔布]]在过去十年内都遭到了撤回，因为有证据表明它们会增加患心脏病和中风的风险。人体的血管内皮细胞原本会合成COX-2。选择性抑制COX-2后，因为血小板里的COX-1未受影响，前列腺素（尤其是[[前列环素|前列环素]]PGI2）的合成相比血栓素会有所降低。这样PGI2抗凝血的保护作用就消失了，这会增加血栓、心肌梗死和其他相关的循环系统疾病的风险。因为血小板没有DNA，它的COX-1若被阿司匹林不可逆地抑制，就无法再生，这是和昔布类可逆抑制剂的不同之处。<ref>{{cite journal |journal=Curr Pharm Des |year=2007 |volume=13 |issue=22 |pages=2215–27 |title=Mechanisms underlying the cardiovascular effects of COX-inhibition: benefits and risks |author=Martínez-González J, Badimon L |pmid=17691994 |doi=10.2174/138161207781368774|last2=Badimon }}</ref><ref>{{cite journal |journal=J Cardiovasc Pharmacol |title=COX-2 inhibitors and cardiovascular risk |author=Funk CD, FitzGerald GA |date=November 2007 |volume=50 |issue=5 |pages=470–9 |pmid=18030055 |doi=10.1097/FJC.0b013e318157f72d|last2=Fitzgerald }}</ref>

此外，阿斯匹靈除了有抑制COX-2的環氧化能力之外，還能將其轉化為類似[[脂加氧酶|脂加氧酶]]的酵素。被阿斯匹靈處理過後的COX-2可以將多種[[多元不飽和脂肪|多元不飽和脂肪酸]]轉為過氧化物，這些過氧化物又會被代謝為具有抗發炎活性的{{Le|特異性促修復介質|specialized proresolving mediators}}，如{{Le|脂氧素|lipoxin}}、{{Le|消散素|resolvins}}、{{Le|巨噬細胞消炎介質|maresin}}等等。<ref name="pmid25895638">{{cite journal|title=Lipoxins and aspirin-triggered lipoxins in resolution of inflammation|url=|journal=[[European_Journal_of_Pharmacology|European Journal of Pharmacology]]|issue=|doi=10.1016/j.ejphar.2015.03.083|year=2015|volume=760|pages=49–63|pmid=25895638|vauthors=Romano M, Cianci E, Simiele F, Recchiuti A}}</ref><ref name="pmid23747022">{{cite journal|title=Resolution phase lipid mediators of inflammation: agonists of resolution|url=|journal=[[Current_Opinion_in_Pharmacology|Current Opinion in Pharmacology]]|issue=4|doi=10.1016/j.coph.2013.05.012|year=2013|volume=13|pages=632–40|pmc=3732499|pmid=23747022|vauthors=Serhan CN, Chiang N}}</ref><ref name="pmid26546723">{{cite journal|title=Docosapentaenoic acid derived metabolites and mediators - The new world of lipid mediator medicine in a nutshell|journal=[[European_Journal_of_Pharmacology|European Journal of Pharmacology]]|issue=|doi=10.1016/j.ejphar.2015.11.002|year=2015|volume=785|pages=108–115|pmid=26546723|vauthors=Weylandt KH}}</ref>

===其他机理===
阿司匹林还有三种作用方式。一是使[[线粒体|线粒体]]的[[氧化磷酸化|氧化磷酸化]]解偶联。阿司匹林会携带[[氢正离子|质子]]从[[线粒体膜间隙|线粒体膜间隙]]扩散进入[[线粒体基质|线粒体基质]]，然后再次[[电离|电离]]释放质子。简而言之，阿司匹林作为[[缓冲剂|缓冲剂]]运输质子，因此高剂量服用时会因[[电子传递链|电子传递链]]释放的热量而造成发热，这和低剂量服用的退烧作用相反。<ref name="SomasundaramS">{{Cite journal|author1=Somasundaram|first2=G|first3=RJ|first4=J|first5=M|first6=IA|first7=S|first8=A|first9=R|issue=5|last2=Sigthorsson|last3=Simpson|last4=Watts|last5=Jacob|last6=Tavares|last7=Rafi|last8=Roseth|last9=Foster |year=2000|title=Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibition of cyclooxygenase are required for the development of NSAID-enteropathy in the rat|journal=Aliment Pharmacol Ther|volume=14|pages=639–650|doi=10.1046/j.1365-2036.2000.00723.x|pmid=10792129|last10=Price|last11=Wrigglesworth|last12=Bjarnason|first10=AB|first12=I| displayauthors=9 }}</ref> 二是阿司匹林会促进[[一氧化氮|一氧化氮]]自由基的生成。一氧化氮自由基本身在小鼠体内也有抗炎的作用，它能减少白细胞粘附，后者是免疫系统应对感染的重要一步。不过，没有足够证据表明阿司匹林能抗感染。<ref>{{Cite journal|first=Mark J. |last=Paul-Clark |first2=Thong van |last2=Cao |first3=Niloufar |last3=Moradi-Bidhendi |first4=Dianne |last4=Cooper |first5=Derek W. |last5=Gilroy |lastauthoramp=yes |title=15-epi-lipoxin A4–mediated Induction of Nitric Oxide Explains How Aspirin Inhibits Acute Inflammation |journal=J. Exp. Med. |year=2004 |volume=200 |issue=1 |pages=69–78 |doi=10.1084/jem.20040566 |pmid=15238606 |pmc=2213311}}</ref> 第三，更新的研究表明水杨酸及其衍生物能通过[[NF-κB|NF-κB]]调节细胞信号。NF-κB是一种[[转录因子|转录因子]]复合体，在许多生物过程（包括发炎）中起重要作用。<ref>{{Cite journal|last=McCarty |first=M. F. |first2=K. I. |last2=Block |year=2006 |title=Preadministration of high-dose salicylates, suppressors of NF-kappaB activation, may increase the chemosensitivity of many cancers: an example of proapoptotic signal modulation therapy |journal=Integr Cancer Ther. |volume=5 |issue=3 |pages=252–268 |pmid=16880431 |doi=10.1177/1534735406291499}}</ref>

阿司匹林在体内分解为水杨酸，而水杨酸本身则有抗炎、退烧、镇痛等作用。2012年发现水杨酸还能激活{{link-en|AMP活化蛋白激酶|AMP-activated protein kinase}}，这是水杨酸和阿司匹林药效的一种可能的解释。<ref>{{cite journal | last1 = Hawley | first1 = S. A. | last2 = Fullerton | first2 = M. D. | last3 = Ross | first3 = F. A. | last4 = Schertzer | first4 = J. D. | last5 = Chevtzoff | first5 = C. | last6 = Walker | first6 = K. J. | last7 = Peggie | first7 = M. W. | last8 = Zibrova | first8 = D. | last9 = Green | first9 = K. A. | last10 = Mustard | first10 = K. J. | last11 = Kemp | first11 = B. E. | last12 = Sakamoto | first12 = K. | last13 = Steinberg | first13 = G. R. | last14 = Hardie | first14 = D. G. | title = The Ancient Drug Salicylate Directly Activates AMP-Activated Protein Kinase | journal = Science | volume = 336 | issue = 6083 | pages = 918–922 | year = 2012 | pmid = 22517326 | pmc = 3399766 | doi = 10.1126/science.1215327 }}</ref><ref>{{cite journal|author=Raffensperger, Lisa|url=http://www.newscientist.com/article/dn21718-clues-to-aspirins-anticancer-effects-revealed.html|title=Clues to aspirin's anti-cancer effects revealed|journal=New Scientist|date=2012-04-19|doi=10.1016/S0262-4079(12)61073-2|volume=214|issue=2862|page=16|access-date=2015-08-17|archive-url=https://web.archive.org/web/20150530020136/http://www.newscientist.com/article/dn21718-clues-to-aspirins-anticancer-effects-revealed.html|archive-date=2015-05-30|dead-url=no}}</ref> 阿司匹林分子中的乙酰基也并非没有作用。细胞蛋白的乙酰化是其[[轉譯後修飾|轉譯後修飾]]中被广泛研究的现象。阿司匹林能使包括COX[[同工酶|同工酶]]在内的几种蛋白质乙酰化。这些乙酰化反应可能可以阐释一些阿司匹林尚未得到解释的效应<ref>{{cite journal | last1 = Bhat | title = Aspirin inhibits camptothecin-induced p21CIP1 levels and potentiates apoptosis in human breast cancer cells | journal = International Journal of Oncology | volume = 34 | issue = 3 | year = 2009 | pmid = 19212664 | pmc =  | doi = 10.3892/ijo_00000185 }}</ref><ref>{{cite journal | last1 = Bhat | title = Does aspirin acetylate multiple cellular proteins? (Review) | journal = Molecular Medicine Reports | volume = 2 | issue = 4 | year = 2009 | pmid = 21475861  | pmc =  | doi = 10.3892/mmr_00000132 }}</ref>。

==药剂学==
[[File:Regular_strength_enteric_coated_aspirin_tablets.jpg|thumb]]
[[Image:5_grain_aspirin.jpg|thumb]]
[[File:Aspirin-Fläschchen.jpg|thumb]]
[[File:BayerHeroin.png|thumb]]、赖塞托和{{link-en|醋氨沙洛|Salophen}}的广告]]
[[File:Aspirine-1923.jpg|thumb]]
[[File:Aspirin1.jpg|right]]
一般来说，成人用于治疗发烧或关节炎时每天服用四次，<ref name=BNF>{{Cite book|title={{le|英國國家處方集|British National Formulary}}|edition=45|year=2003|publisher= [[British_Medical_Journal|British Medical Journal]] and {{le|英國皇家藥劑師協會|Royal Pharmaceutical Society of Great Britain}}}}</ref> 这和以前治疗风湿热时所用的剂量接近。<ref>{{cite web |url=http://www.medscape.com/druginfo/monograph?cid=med&drugid=3881&drugname=Aspirin+EC+Oral&monotype=monograph |title=Aspirin monograph: dosages, etc |publisher=Medscape.com |accessdate=2011-05-11 |archive-date=2019-07-13 |archive-url=https://web.archive.org/web/20190713075907/https://reference.medscape.com/ |dead-url=no }}</ref> 有或怀疑有冠状动脉病史的人要预防[[心肌梗塞|心肌梗塞]]（MI），每天低剂量服用一次即可。<ref name=BNF />

USPSTF在2009年3月向45-79岁的男性和55-79岁的女性建议，如果阿司匹林降低男性心肌梗死和女性中风的风险所带来的潜在效益要大于引起消化道出血的潜在危害，那么就提倡服用该药以预防冠状动脉心脏疾病。<ref name=medscape>{{cite web |url=http://cme.medscape.com/viewarticle/589895?src=cmemp |title=Aspirin: More Evidence That Low Dose Is All That Is Needed (from Medscape) |publisher=Cme.medscape.com |accessdate=2011-05-11 |archive-date=2019-07-13 |archive-url=https://web.archive.org/web/20190713075909/https://login.medscape.com/login/sso/getlogin?urlCache=aHR0cHM6Ly93d3cubWVkc2NhcGUub3JnL3ZpZXdhcnRpY2xlLzU4OTg5NT9zcmM9Y21lbXA=&ac=401 |dead-url=yes }}</ref> WHI的研究表明女性如果坚持低剂量（75毫克或81毫克）服用，死于心血管疾病的风险就会降低25%，总死亡率降低14%。<ref name=medscape /> 低剂量服用阿司匹林（每天75毫克或81毫克）也和心血管疾病发病率降低有关，长期服用以预防疾病的患者利用这种方式可以兼顾药物的有效性和安全性。<ref name=medscape />

儿童服用阿司匹林治疗[[川崎病|川崎病]]时，服用剂量和体重相关，头两周每天服用四次，接下来六至八周降低剂量，每天服用一次。<ref>{{Cite book|title={{le|英國國家處方集兒童版|British National Formulary for Children|British National Formulary for Children}}|year=2006|publisher= [[British_Medical_Journal|British Medical Journal]] and {{le|英國皇家藥劑師協會|Royal Pharmaceutical Society|Royal Pharmaceutical Society}}}}</ref>

==药代动力学==
乙酰水杨酸是一种[[弱酸|弱酸]]，口服后在[[胃|胃]]的[[胃酸|酸性环境]]中几乎不[[电离|电离]]，而是迅速经[[细胞膜|细胞膜]]吸收。[[小肠|小肠]]中较高的[[pH|pH]]促进了药物的电离，从而减缓了药物在小肠中的吸收。过量服用时药物会凝结，所以吸收更慢，血浆浓度在服用后24小时内都会上升。<ref name="'RK Ferguson'">{{Cite journal|title=Death following self-poisoning with aspirin|journal=Journal of the American Medical Association|date=1970-08-17|first1=RK|last1=Ferguson|author2=Boutros, AR|volume=213|issue=7|pages=1186–8|pmid=5468267|doi=10.1001/jama.213.7.1186}}</ref><ref name="'FL Kaufman'">{{Cite journal|title=Darvon poisoning with delayed salicylism: a case report|journal=Pediatrics|date=April 1970|first1=FL|last1=Kaufman|author2=Dubansky, AS|volume=49|issue=4|pages=610–1|pmid=5013423}}</ref><ref name="G Levy">{{Cite journal |doi=10.1056/NEJM197208312870903|title=Salicylate accumulation kinetics in man |journal=New England Journal of Medicine |date=1972-08-31 |first1=G |last1=Levy |author2=Tsuchiya, T |volume=287 |issue=9 |pages=430–2 |pmid=5044917}}</ref>

血液中的水杨酸有50–80%与[[白蛋白|白蛋白]]结合，其余是具有活性的电离态。药物和蛋白质的结合和浓度有关。结合位点饱和以后游离态的水杨酸就会增加，其毒性也会增强。药物的[[分布体积|分布体积]]是0.1–0.2升每千克。酸中毒会增强水杨酸向组织中的渗透，从而增加药物的分布体积。<ref name="G Levy"/>

若按治疗剂量服用，则有多达80%的水杨酸在[[肝脏|肝脏]]中[[代谢|代谢]]。它和[[甘氨酸|甘氨酸]]反应生成{{link-en|水杨酰胺乙酸|salicyluric acid}}，但这种[[代谢途径|代谢途径]]容量有限。少量水杨酸也会羟基化形成[[龙胆酸|龙胆酸]]。大剂量服用时，药物代谢从一级反应变为零级反应，因为代谢途径已饱和，[[肾脏|肾脏]]的排出变得更加重要。<ref name="G Levy"/>

水杨酸主要通过肾脏作为水杨酰胺乙酸（75%）、游离水杨酸（10%）、水杨酸苯酚（10%）、酰基葡萄糖醛酸苷（5%）、[[龙胆酸|龙胆酸]]（< 1%）、[[2,3-二羟基苯甲酸|2,3-二羟基苯甲酸]]排泄。<ref>2,3-Dihydroxybenzoic acid is a product of human aspirin metabolism. Martin Grootveld and Barry Halliwell, Biochemical Pharmacology, Volume 37, Issue 2, 15 January 1988, pages 271–280, {{doi|10.1016/0006-2952(88)90729-0}}</ref>当摄入低剂量时（小于250mg，成人），所有途径都通过一级动力学，[[消除半衰期|消除半衰期]]约为2.0至4.5小时。<ref name="'O Hartwig'">{{Cite journal|title=Pharmacokinetic considerations of common analgesics and antipyretics|journal=American Journal of Medicine|date=1983-11-14|first=Otto H|last=Hartwig|volume=75|issue=5A|pages=30–7|pmid=6606362|doi=10.1016/0002-9343(83)90230-9}}</ref><ref name="'AK Done'">{{Cite journal|title=Salicylate intoxication. Significance of measurements of salicylate in blood in cases of acute ingestion|url=https://archive.org/details/sim_pediatrics_1960-11_26_5/page/800|journal=Pediatrics|date=November 1960|first=AK|last=Done|volume=26|pages=800–7|pmid=13723722}}</ref> 当摄入高剂量水杨酸时（大于4000mg），半衰期会延长至15-30小时，<ref name="Chyka2007">{{Cite journal|author=Chyka PA, Erdman AR, Christianson G, Wax PM, Booze LL, Manoguerra AS, Caravati EM, Nelson LS, Olson KR, Cobaugh DJ, Scharman EJ, Woolf AD, Troutman WG; Americal Association of Poison Control Centers; Healthcare Systems Bureau, Health Resources and Services Administration, Department of Health and Human Services. |title=Salicylate poisoning: an evidence-based consensus guideline for out-of-hospital management |journal=Clin Toxicol (Phila) |volume=45 |issue=2 |pages=95–131 |year=2007 |pmid=17364628 |doi=10.1080/15563650600907140}}</ref>因为水杨酰胺乙酸和水杨酚醛葡糖苷酸的生物转化途径已饱和。<ref>{{Cite journal|author=Prescott LF, Balali-Mood M, Critchley JA, Johnstone AF, Proudfoot AT |title=Diuresis or urinary alkalinisation for salicylate poisoning? |journal=Br Med J (Clin Res Ed) |volume=285 |issue=6352 |pages=1383–6 |year=1982 |pmid=6291695 |pmc=1500395 |doi=10.1136/bmj.285.6352.1383|last2=Balali-Mood |last3=Critchley |last4=Johnstone |last5=Proudfoot }}</ref> 代谢途径的饱和使得肾脏对水杨酸的排泄更加重要，而[[尿液|尿液]][[酸碱度|酸碱度]]对其影响也更为敏感。当尿液的pH值从5升至8时，肾脏对水杨酸的清除能力会提升10-20倍。通过碱化尿液来增加水杨酸的清除率便是利用了这一点。<ref name="EmergMed2002-Dargan">{{Cite journal|author=Dargan PI, Wallace CI, Jones AL.|title=An evidenced based flowchart to guide the management of acute salicylate (aspirin) overdose|journal=Emerg Med J|year=2002|pages=206–9|volume=19|issue=3|pmid= 11971828 |doi=10.1136/emj.19.3.206|pmc=1725844|last2=Wallace|last3=Jones}}</ref>

==历史==
自古以来，人们就知道含有活性成分水杨酸的植物提取物（如[[柳树|柳树]][[树皮|皮]]和[[绣线菊属|绣线菊属]]植物）能够镇痛、退烧。[[希波克拉底|希波克拉底]]（约前460年–前377年）留下的历史记录就描述了柳树的树皮和树叶磨成的粉能够缓解以上症状。<ref>{{cite web|author=Mary Bellis |url=http://inventors.about.com/library/inventors/blaspirin.htm |title=History of aspirin |publisher=Inventors.about.com |date=2010-06-16 |accessdate=2011-05-11}}</ref>

1763年英国牧师{{link-en|爱德华·斯通|Edward Stone (cleric)}}在牛津发现阿司匹林的活性成分水杨酸。法国化学家{{link-en|查尔斯·弗雷德里克·格哈特|Charles Frédéric Gerhardt}}首先于1853年合成了乙酰水杨酸。他在制取和研究各种[[酸酐|酸酐]]的性质时，把[[乙酰氯|乙酰氯]]和[[水杨酸钠|水杨酸钠]]混合，二者发生剧烈反应，熔化后又很快凝固了。因为当时还没有{{link-en|分子结构理论|Structural theory}}，格哈特把所得的化合物称为“水杨酸乙酸酐”（''wasserfreie Salicylsäure-Essigsäure''）。他为撰写关于酸酐的论文进行了很多反应，这个制备阿司匹林的反应只是其中之一，后来他也没有进一步研究。<ref name=gerhardt>{{Cite journal|author=Gerhardt, Ch.|title=Untersuchungen über die wasserfreien organischen Säuren|trans_title=Investigations into anhydrous organic acids|journal=Annalen der Chemie und Pharmacie|volume=87|pages=149–179|year=1853|url=https://books.google.com/books?id=Wus2AAAAYAAJ&pg=PA149#v=onepage&q&f=false|doi=10.1002/jlac.18530870107|language=de|access-date=2015-08-24|archive-date=2015-07-13|archive-url=https://web.archive.org/web/20150713190607/https://books.google.com/books?id=Wus2AAAAYAAJ&pg=PA149#v=onepage&q&f=false|dead-url=no}}  特别是162–163页.</ref>
六年之后的1859年，冯·基尔姆让水杨酸和乙酰氯反应，制得了分析纯的乙酰水杨酸，他称之为“乙酰化水杨酸”（'' acetylierte Salicylsäure''）<ref name=gilm>{{Cite journal|author=von Gilm H|title=Acetylderivate der Phloretin- und Salicylsäure|trans_title=Acetyl derivatives of phloretic and salicylic acids|journal=Annalen der Chemie und Pharmacie|volume=112|issue=2|pages=180–182|year=1859|url=https://books.google.com/books?id=NYs8AAAAIAAJ&pg=RA1-PA180#v=onepage&q&f=false|doi=10.1002/jlac.18591120207|language=de|access-date=2015-08-24|archive-date=2015-07-13|archive-url=https://web.archive.org/web/20150713190609/https://books.google.com/books?id=NYs8AAAAIAAJ&pg=RA1-PA180#v=onepage&q&f=false|dead-url=no}}</ref> 1869年，施罗德、普林兹霍恩和克劳特重复了格哈特（利用水杨酸钠）的和基尔姆（利用水杨酸）的合成方式，结果证实两个反应产物相同——乙酰水杨酸。他们第一次确定了产物的正确结构——乙酰基和酚基上的氧相连。<ref>{{Cite journal|author=Schröder, Prinzhorn, Kraut K|title=Ueber Salicylverbindungen|trans_title=On compounds of salicylic acid|journal=Annalen der Chemie und Pharmacie|volume=150|issue=1|pages=1–20|year=1869|url=http://babel.hathitrust.org/cgi/pt?id=uva.x002457978;view=1up;seq=399|doi=10.1002/jlac.18691500102|last2=Prinzhorn|last3=Kraut|language=de|access-date=2015-08-24|archive-date=2015-09-03|archive-url=https://web.archive.org/web/20150903182508/http://babel.hathitrust.org/cgi/pt?id=uva.x002457978;view=1up;seq=399|dead-url=no}}特别是9–13页，乙酰水杨酸的结构在12页上。</ref>
1897年[[拜耳|拜耳]]公司的化学家把[[旋果蚊子草|旋果蚊子草]]（''Filipendula ulmaria''）合成的[[水杨苷|水杨苷]]经过修饰后合成了一种药物，它比纯净的水杨酸对消化道刺激更小。这个项目由哪个化学家领衔存在争议。拜耳说合成是由[[费利克斯·霍夫曼|费利克斯·霍夫曼]]完成的，但后来犹太化学家{{link-en|阿瑟·艾兴格林|Arthur Eichengrün}}声称他才是首席研究员，而他的贡献记录被[[納粹德國|纳粹]]政权抹去了。<ref>{{cite journal|last1=Mahdi|first1=JG|author2=Mahdi, AJ, Mahdi, AJ, Bowen, ID|title=The historical analysis of aspirin discovery, its relation to the willow tree and antiproliferative and anticancer potential|journal=Cell proliferation|date=April 2006|volume=39|issue=2|pages=147–55|pmid=16542349|doi=10.1111/j.1365-2184.2006.00377.x}}</ref><ref name="Distillations">{{cite journal |last1=Dick |first1=Brian |title=Hard Work and Happenstance |url=https://www.sciencehistory.org/distillations/magazine/hard-work-and-happenstance |journal=Distillations |publisher=[[Science_History_Institute|Science History Institute]] |date=2018 |volume=4 |issue=1 |pages=44-45 |accessdate=2018-07-11 |author= |archive-url=https://web.archive.org/web/20180711234027/https://www.sciencehistory.org/distillations/magazine/hard-work-and-happenstance |archive-date=2018-07-11 |dead-url=no }}</ref>这种药学名叫乙酰水杨酸，拜耳公司把它称为阿司匹林（Aspirin），这来自于旋果蚊子草的植物名（''{{lang-la|Filipendula ulmaria}}''）。<ref>{{cite journal |last=Singer |first=H. |title=Ueber Aspirin |journal=Pflügers Archiv: European Journal of Physiology |volume=84 |issue=11–12 |year=1901 |pages=527–546 |doi=10.1007/BF01769129}}</ref> 到了1899年，拜耳已在全球市场销售此药。<ref name=Jeffreys_73>{{Harvnb|Jeffreys|2005|pp=73}}</ref>

二十世纪上半叶，阿司匹林越来越受欢迎，这是因为人们认为它在[[1918年流感大流行|1918年流感大流行]]中发挥了作用。然而最近的研究却显示，它也是流感致死率高的部分原因，不过这种说法颇受争议，未被广泛认可。<ref>{{cite journal|last1=Starko|first1=Karen M.|title = Salicylates and Pandemic Influenza Mortality, 1918–1919 Pharmacology, Pathology, and Historic Evidence |journal=Clinical Infectious Diseases|volume=49|year=2009|doi=10.1086/606060|issue=9|pmid=19788357|pages=1405–1410}}</ref> 阿司匹林带来的丰厚利润使药厂激烈竞争，该药的各种品牌和产品像雨后春笋般冒了出来，在1917年拜耳公司的美国专利过期了以后更是如此。<ref name=Jeffreys_136>{{Harvnb|Jeffreys|2005|pp=136–142, 151–152}}</ref><ref>{{cite web |url=http://www.history.com/this-day-in-history.do?action=VideoArticle&id=52415 |title=Bayer patents aspirin – This Day in History – 3/6/1899 |publisher=History.com |accessdate=2011-05-11 |deadurl=yes |archiveurl=https://web.archive.org/web/20091008193942/http://www.history.com/this-day-in-history.do?action=VideoArticle&id=52415 |archivedate=2009-10-08 }}</ref> [[对乙酰氨基酚|对乙酰氨基酚]]和[[布洛芬|布洛芬]]于1956年和1959年相继问世以后，阿司匹林的使用率开始下降。<ref name=Jeffreys_212>{{Harvnb|Jeffreys|2005|pp=212–217}}</ref>60和70年代，[[约翰·范恩|约翰·范恩]]等人发现了阿司匹林的作用机理，60至80年代的其他研究和临床试验证明该药有抗凝血的药效，可降低血栓疾病的发病率。<ref name=Jeffreys_226>{{Harvnb|Jeffreys|2005|pp=226–231}}</ref>
由于广泛用于预防心脏病和中风，阿司匹林的销量从20世纪末开始复苏，21世纪以来持续向好。<ref name=Jeffreys_267>{{Harvnb|Jeffreys|2005|pp=267–269}}</ref>

=== 商标 ===
德国在一战中投降后，1919年各国签订的[[凡尔赛条约|凡尔赛条约]]中[[第一次世界大战的赔款|战后赔偿]]的部分规定阿司匹林（Aspirin）连同[[海洛因|海洛因]]在法国、俄罗斯、英国和美国不再是注册商标，而成为了通用名称。<ref>{{cite web
 |url          = http://en.wikisource.org/wiki/Treaty_of_Versailles/Part_X#Article_298
 |date         = 1919-06-28
 |title        = Treaty of Versailles, Part X, Section IV, Article 298
 |accessdate   = 2008-10-25
 |pages        = Annex, Paragraph 5
 |archive-url  = https://web.archive.org/web/20081211051417/http://en.wikisource.org/wiki/Treaty_of_Versailles/Part_X#Article_298
 |archive-date = 2008-12-11
 |dead-url     = no
}}</ref><ref>{{Cite journal | last = Mehta | first = Aalok | title = Aspirin | journal = Chemical & Engineering News | volume = 83 | issue = 25 | year = 2005 | url = http://pubs.acs.org/cen/coverstory/83/8325/8325aspirin.html | accessdate = 2008-10-23 | archive-date = 2008-10-11 | archive-url = https://web.archive.org/web/20081011091220/http://pubs.acs.org/cen/coverstory/83/8325/8325aspirin.html | dead-url = no }}</ref><ref>{{cite web |url=http://www.ul.ie/~childsp/CinA/Issue59/TOC43_Aspirin.htm |title=The Centenary of Aspirin |publisher=Ul.ie |date=1999-03-06 |accessdate=2011-05-11 |archive-url=https://web.archive.org/web/20110408220757/http://www.ul.ie/~childsp/CinA/Issue59/TOC43_Aspirin.htm |archive-date=2011-04-08 |dead-url=no }}</ref> 现在aspirin（a小写）在澳大利亚、法国、印度、爱尔兰、新西兰、巴基斯坦、牙买加、哥伦比亚、菲律宾、南非、英国和美国是通用名称，而Aspirin（a大写）在德国、加拿大、墨西哥等80多个国家还是拜耳公司的注册商标。公司在所有市场上出售的药物成分都是乙酰水杨酸，但包装和物理性质则在各个市场都不相同。<ref>{{Cite news | url=http://www.cbc.ca/health/story/2009/05/28/f-aspirin-studies.html | work=CBC News | title=Aspirin: the versatile drug | date=2009-05-28 | access-date=2015-08-24 | archive-url=https://web.archive.org/web/20110119222443/http://www.cbc.ca/health/story/2009/05/28/f-aspirin-studies.html | archive-date=2011-01-19 | dead-url=no }}</ref><ref>
 {{Cite journal | last = Cheng | first = Tsung O. | title = The History of Aspirin | journal = Texas Heart Institute Journal | volume = 34 | issue = 3 | pages = 392–393 | pmid = 17948100 | year = 2007 | pmc = 1995051 }}</ref>

==兽用==
兽医有时用阿司匹林来镇痛或抗血栓，主要给狗用，有时给马用，不过现在一般会用副作用较少的新疗法<ref name="aavpt">{{cite web |author1=American Academy of Veterinary Pharmacology and Therapeutics |title=ASPIRIN Veterinary—Systemic |url=http://c.ymcdn.com/sites/www.aavpt.org/resource/resmgr/imported/aspirin.pdf |accessdate=2016-02-25 |archivedate=2016-02-25 |deadurl=yes |archiveurl=https://web.archive.org/web/20160225085340/http://c.ymcdn.com/sites/www.aavpt.org/resource/resmgr/imported/aspirin.pdf }}</ref>。

狗和马都会出现水杨酸产生的胃肠道副作用，不过阿司匹林可以用来治疗老年狗的[[关节炎|关节炎]]，也有治疗马的{{link-en|蹄叶炎|laminitis}}的可能。<ref>{{cite web|last = Crosby|first = Janet Tobiassen|title = Veterinary Questions and Answers|publisher = About.com|year = 2006|url = http://vetmedicine.about.com/cs/altvetmedgeneral/a/dogcataspirin.htm|accessdate = 2007-09-05|archiveurl = https://web.archive.org/web/20070908151020/http://vetmedicine.about.com/cs/altvetmedgeneral/a/dogcataspirin.htm|archivedate = 2007-09-08|deadurl = yes}}</ref><ref name="CambridgeH">{{Cite journal|author=Cambridge H, Lees P, Hooke RE, Russell CS|title=Antithrombotic actions of aspirin in the horse |journal=Equine Vet J |volume=23 |issue=2 |pages=123–7 |year=1991 |pmid=1904347|doi=10.1111/j.2042-3306.1991.tb02736.x|last2=Lees |last3=Hooke |last4=Russell }}</ref> 不过现在该药已很少用于治疗蹄叶炎，因为可能适得其反。阿司匹林应该只在[[兽医|兽医]]的直接指导下使用，特别是猫，因其缺乏有助于药物排出的[[葡萄糖醛酸|葡萄糖醛酸]]，用药比较危险。<ref>{{cite book|editor=Lappin, Michael R.|title=Feline internal medicine secrets|year=2001|publisher=Hanley & Belfus|location=Philadelphia|isbn=1-56053-461-3|page=160}}</ref> 连续4周每48小时给猫服用25毫克/千克体重的阿司匹林并不产生临床中毒症状。<ref>{{cite web|url=http://www.merckmanuals.com/vet/toxicology/toxicities_from_human_drugs/analgesics_toxicity.html|title=Analgesics (Toxicity): Toxicities from Human Drugs: Merck Veterinary Manual|accessdate=2015-08-24|archive-url=https://web.archive.org/web/20150411095033/http://www.merckmanuals.com/vet/toxicology/toxicities_from_human_drugs/analgesics_toxicity.html|archive-date=2015-04-11|dead-url=no}}</ref> 推荐用于猫的解热镇痛剂量是每48小时10毫克/千克体重。<ref>{{cite web|url=http://www.ansci.cornell.edu/plants/toxcat/toxcat.html|title=Plants Poisonous to Livestock - Cornell University Department of Animal Science|accessdate=2015-08-24|archive-url=https://web.archive.org/web/20150816192109/http://www.ansci.cornell.edu/plants/toxcat/toxcat.html|archive-date=2015-08-16|dead-url=no}}</ref>

== 参见 ==
* [[非專利藥|非專利藥]]

==註釋==
{{reflist|group="注"}}

==參考資料==
{{Reflist|30em}}

==延伸阅读==
* {{Cite book|last1=Jeffreys |first1=Diarmuid |title= Aspirin: The Remarkable Story of a Wonder Drug|publisher = Bloomsbury USA|date = 2005-08-11|isbn=1-58234-600-3|ref=harv}}

==外部链接==
{{Commons|Aspirin}}
* [http://www.nextbio.com/b/home/home.nb?q=aspirin NextBio中Aspirin的条目]{{Wayback|url=http://www.nextbio.com/b/home/home.nb?q=aspirin |date=20081218224236 }}
* [https://in.news.yahoo.com/scientific-review-finds-aspirin-significantly-cuts-cancer-rates-005137509--finance.html 阿司匹林降低癌症发病率]{{Wayback|url=https://in.news.yahoo.com/scientific-review-finds-aspirin-significantly-cuts-cancer-rates-005137509--finance.html |date=20151015200126 }}
* [http://www.periodicvideos.com/videos/mv_aspirin.htm Aspirin 元素周期表视频（诺丁汉大学）]{{Wayback|url=http://www.periodicvideos.com/videos/mv_aspirin.htm |date=20150909025035 }}
* [http://www.creatingtechnology.org/biomed/aspirin.htm 阿司匹林背后的科学]{{Wayback|url=http://www.creatingtechnology.org/biomed/aspirin.htm |date=20100114133831 }}
* {{cite web|first = Shauna|last = Roberts|publisher = American Chemical Society|title = Take two: Aspirin|url = http://pubs.acs.org/subscribe/journals/mdd/v03/i08/html/10health.html|quote = New uses and new dangers are still being discovered as aspirin enters its 2nd century（阿司匹林面世后一百多年，人们仍在发现它的新用途和风险）|accessdate = 2015-08-24|archive-date = 2008-09-07|archive-url = https://web.archive.org/web/20080907061937/http://pubs.acs.org/subscribe/journals/mdd/v03/i08/html/10health.html|dead-url = no}}
* {{Cite encyclopedia|last = Ling|first = Greg|title = Aspirin|encyclopedia = How Products are Made|volume = 1|publisher = Thomson Gale|year = 2005|url = http://www.madehow.com/Volume-1/Aspirin.html|access-date = 2015-08-24|archive-date = 2010-01-03|archive-url = https://web.archive.org/web/20100103010802/http://madehow.com/Volume-1/Aspirin.html|dead-url = no}}
* [http://druginfo.nlm.nih.gov/drugportal/dpdirect.jsp?name=Aspirin 美国国家医学图书馆：药品信息门户 – 阿司匹林]{{Wayback|url=http://druginfo.nlm.nih.gov/drugportal/dpdirect.jsp?name=Aspirin |date=20100609053347 }}
* [http://www.cdc.gov/niosh/npg/npgd0010.html CDC – 美国国家职业安全卫生研究所危险化学品袖珍指南 – 乙酰水杨酸]{{Wayback|url=http://www.cdc.gov/niosh/npg/npgd0010.html |date=20150530222806 }}
* [http://jingyan.baidu.com/article/adc815133990a0f723bf73f5.html 阿司匹林的十大妙用]{{Wayback|url=http://jingyan.baidu.com/article/adc815133990a0f723bf73f5.html |date=20190304124320 }}
* [http://movie.douban.com/subject/1464548/ 电影《阿司匹林》 (2006)]{{Wayback|url=http://movie.douban.com/subject/1464548/ |date=20150214071944 }}
* [https://www.aboutkidshealth.ca/article?contentid=77&language=ChineseTraditional 乙醯水楊酸 (ASA)]{{Wayback|url=https://www.aboutkidshealth.ca/article?contentid=77&language=ChineseTraditional |date=20190920124743 }}
* [https://www.mohw.gov.tw/fp-16-25501-1.html 乙醯水楊酸藥品（acetylsalicylic acid）警語及注意事項應依規定標示，食品藥物管理局將請衛生局進行查核，如標示不符合規定者依法處辦- 衛生福利部]{{Wayback|url=https://www.mohw.gov.tw/fp-16-25501-1.html |date=20191205083715 }}
* [https://www.commonhealth.com.tw/article/article.action?nid=63815 該將阿斯匹靈當維他命？ - 康健雜誌]{{Wayback|url=https://www.commonhealth.com.tw/article/article.action?nid=63815 |date=20200901123403 }}
* [https://case.ntu.edu.tw/blog/?p=5072 【書評介紹】阿司匹林傳奇—千年靈藥的偵探故事 | CASE報科學]{{Wayback|url=https://case.ntu.edu.tw/blog/?p=5072 |date=20200901123442 }}

{{苯}}
{{Antithrombotics}}
{{Anti-inflammatory products}}
{{止痛药}}
{{抗痤疮制剂}}
{{Salicylates}}
{{国家基本药物目录/镇痛、解热、抗炎、抗风湿、抗痛风药}}
{{Authority control}}

[[Category:阿司匹林|Category:阿司匹林]]
[[Category:非甾体抗炎药|Category:非甾体抗炎药]]
[[Category:抗血小板药|Category:抗血小板药]]
[[Category:苯甲酸衍生物|Category:苯甲酸衍生物]]
[[Category:世界卫生组织基本药物|Category:世界卫生组织基本药物]]
[[Category:乙酸酯|Category:乙酸酯]]
[[Category:拜耳|Category:拜耳]]
[[Category:水杨酸|Category:水杨酸]]
[[Category:肝毒素|Category:肝毒素]]